<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>Small Animal Medicine Society</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki</link><description /><dc:language>en-US</dc:language><generator>Telligent Community 10</generator><item><title>Small Animal Medicine Society</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki</link><pubDate>Thu, 02 Jul 2015 07:03:40 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:d66f072f-7d26-478c-978c-b4f2ef71f116</guid><dc:creator>Anonymous</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Anonymous on 7/2/2015 7:03:40 AM&lt;br /&gt;
&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>RVC Diabetic Remission Clinic</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1161/rvc-diabetic-remission-clinic</link><pubDate>Thu, 09 Jan 2014 12:02:29 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:040c2fdf-8fd1-4f08-99e1-2c1a63f1720c</guid><dc:creator>Stijn Niessen</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Stijn Niessen on 1/9/2014 12:02:29 PM&lt;br /&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:12pt 15pt 2.4pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#8f23b3;font-size:10.5pt;mso-fareast-language:EN-GB;"&gt;&lt;strong&gt;Feline Diabetic Remission Clinic&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;The Royal Veterinary College&amp;nbsp;is busy unravelling the riddle for the best treatment of diabetes mellitus in cats. &amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Dr. Stijn Niessen and his team have officially launched a new Feline Diabetic Remission Clinic in the Queen Mother Hospital for Animals in Hertfordshire, to investigate the optimum methods to achieve good control, and ultimately diabetic remission, in diabetic cats.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Cats examined through the new clinic will benefit from a host of incentives, including &lt;b&gt;free food and insulin&lt;/b&gt;, as well as optimum diabetic management, with the support of Internal Medicine Specialists, while also contributing immensely to the current scientific knowledge on the best treatment for diabetic cats.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;As we all know, feline diabetes mellitus is a costly, chronic disease which can significantly decrease the quality of life of both cat owners and their pets. However, a proportion of diabetic cats can achieve diabetic remission and no longer require insulin therapy, which is increasingly considered the ultimate goal in treating diabetic cats. &amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Early evidence suggests that good, early blood glucose control increases remission rates in diabetic cats. However, there is little evidence about which treatment protocol offers the best blood glucose control and chance of remission.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;The clinic is currently recruiting cats that have had diabetes for less than 4 months&amp;#39; duration for a clinical trial, examining the effect of new insulins on blood glucose control and remission rate.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 51pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Enrolled cats will qualify for full underlying disease assessment at the referral hospital, several re-examination appointments, 12 months of prescription diabetic food, and 6 months of insulin therapy &amp;ndash;&lt;b&gt; all at no cost to owners. &lt;/b&gt;The latest updates on the clinic can be found on its Facebook-website: &lt;a  target='_blank'  href="http://www.facebook.com/RVC.Diabetic.Remission.Clinic"&gt;&lt;span style="color:#0000ff;"&gt;www.facebook.com/RVC.Diabetic.Remission.Clinic&lt;/span&gt;&lt;/a&gt; and the clinic can be contacted on &lt;a  target='_blank'  href="mailto:fdrc@rvc.ac.uk"&gt;&lt;span style="color:#0000ff;"&gt;fdrc@rvc.ac.uk&lt;/span&gt;&lt;/a&gt; or by calling CIC on 01707666605. Please also &amp;quot;like&amp;quot; our Facebook-page and help spread the word :-)&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 51pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;We are also interested in receiving &lt;b&gt;blood samples from all diabetic cats&lt;/b&gt;, regardless of duration of diabetes mellitus. In return we are offering &lt;b&gt;free fructosamine,&lt;/b&gt; cholesterol and triglycerides, please see the sample submission form below. Newly diagnosed cats (diagnosis within the last 6 weeks) are also eligible for follow up samples for 4 months.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 51pt 12pt 36pt;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;&lt;a  target='_blank'  href="http://www.rvc.ac.uk/CIC/documents/GHSubmissionformV14KM09JAN2014.pdf"&gt;&lt;span style="color:#8f23b3;text-decoration:none;text-underline:none;"&gt;Download the Diabetic Cat Submission form here&lt;/span&gt;&lt;/a&gt;&amp;nbsp;&lt;a  target='_blank'  href="http://www.rvc.ac.uk/CIC/documents/GHSubmissionformV14KM09JAN2014.pdf"&gt;http://www.rvc.ac.uk/CIC/documents/GHSubmissionformV14KM09JAN2014.pdf&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Please note that samples older than 4 days may not provide reliable fructosamine results so we would advise against sending samples on a Friday.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Thank you very very much for helping us improve the welfare of cats with diabetes!&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Diagnose a cat with diabetes: think of us!&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Regards,&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Stijn.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;

&lt;div style="font-size: 90%;"&gt;Tags: Diabetes Cat Free food and insulin&lt;/div&gt;
</description></item><item><title>RVC Diabetic Remission Clinic</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1161/rvc-diabetic-remission-clinic/revision/1</link><pubDate>Thu, 09 Jan 2014 12:00:30 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:040c2fdf-8fd1-4f08-99e1-2c1a63f1720c</guid><dc:creator>Stijn Niessen</dc:creator><description>Revision 1 posted to Small Animal Medicine Society by Stijn Niessen on 1/9/2014 12:00:30 PM&lt;br /&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:12pt 15pt 2.4pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#8f23b3;font-size:10.5pt;mso-fareast-language:EN-GB;"&gt;Feline Diabetic Remission Clinic&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;The Royal Veterinary College&amp;nbsp;is busy unravelling the riddle for the best treatment of diabetes mellitus in cats. &amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Dr. Stijn Niessen and his team have officially launched a new Feline Diabetic Remission Clinic in the Queen Mother Hospital for Animals in Hertfordshire, to investigate the optimum methods to achieve good control, and ultimately diabetic remission, in diabetic cats.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Cats examined through the new clinic will benefit from a host of incentives, including &lt;b&gt;free food and insulin&lt;/b&gt;, as well as optimum diabetic management, with the support of Internal Medicine Specialists, while also contributing immensely to the current scientific knowledge on the best treatment for diabetic cats.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;As we all know, feline diabetes mellitus is a costly, chronic disease which can significantly decrease the quality of life of both cat owners and their pets. However, a proportion of diabetic cats can achieve diabetic remission and no longer require insulin therapy, which is increasingly considered the ultimate goal in treating diabetic cats. &amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Early evidence suggests that good, early blood glucose control increases remission rates in diabetic cats. However, there is little evidence about which treatment protocol offers the best blood glucose control and chance of remission.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;The clinic is currently recruiting cats that have had diabetes for less than 4 months&amp;#39; duration for a clinical trial, examining the effect of new insulins on blood glucose control and remission rate.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 51pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Enrolled cats will qualify for full underlying disease assessment at the referral hospital, several re-examination appointments, 12 months of prescription diabetic food, and 6 months of insulin therapy &amp;ndash;&lt;b&gt; all at no cost to owners. &lt;/b&gt;The latest updates on the clinic can be found on its Facebook-website: &lt;a  target='_blank'  href="http://www.facebook.com/RVC.Diabetic.Remission.Clinic"&gt;&lt;span style="color:#0000ff;"&gt;www.facebook.com/RVC.Diabetic.Remission.Clinic&lt;/span&gt;&lt;/a&gt; and the clinic can be contacted on &lt;a  target='_blank'  href="mailto:fdrc@rvc.ac.uk"&gt;&lt;span style="color:#0000ff;"&gt;fdrc@rvc.ac.uk&lt;/span&gt;&lt;/a&gt; or by calling CIC on 01707666605.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 51pt 12pt 0cm;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;We are also interested in receiving &lt;b&gt;blood samples from all diabetic cats&lt;/b&gt;, regardless of duration of diabetes mellitus. In return we are offering &lt;b&gt;free fructosamine,&lt;/b&gt; cholesterol and triglycerides, please see the sample submission form below. Newly diagnosed cats (diagnosis within the last 6 weeks) are also eligible for follow up samples for 4 months.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 51pt 12pt 36pt;background:white;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;&lt;a  target='_blank'  href="http://www.rvc.ac.uk/CIC/documents/GHSubmissionformV14KM09JAN2014.pdf"&gt;&lt;span style="color:#8f23b3;text-decoration:none;text-underline:none;"&gt;Download the Diabetic Cat Submission form here&lt;/span&gt;&lt;/a&gt;&amp;nbsp;&lt;a  target='_blank'  href="http://www.rvc.ac.uk/CIC/documents/GHSubmissionformV14KM09JAN2014.pdf"&gt;http://www.rvc.ac.uk/CIC/documents/GHSubmissionformV14KM09JAN2014.pdf&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Please note that samples older than 4 days may not provide reliable fructosamine results so we would advise against sending samples on a Friday.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Thank you very very much for helping us improve the welfare of cats with diabetes!&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Diagnose a cat with diabetes: think of us!&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Regards,&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 15pt 12pt 0cm;background:white;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;,&amp;#39;sans-serif&amp;#39;;color:#333333;font-size:9pt;mso-fareast-language:EN-GB;"&gt;Stijn.&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;

&lt;div style="font-size: 90%;"&gt;Tags: Diabetes Cat Free food and insulin&lt;/div&gt;
</description></item><item><title>Canine inflammatory bowel disease (IBD) in German Shepherd Dogs</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1140/canine-inflammatory-bowel-disease-ibd-in-german-shepherd-dogs</link><pubDate>Mon, 11 Mar 2013 19:22:24 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:61ccc6bf-e982-4158-ae8c-14c4502e641f</guid><dc:creator>Fabio Procoli</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Fabio Procoli on 3/11/2013 7:22:24 PM&lt;br /&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;Dear SamSoc members&lt;/span&gt;&lt;/b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;,&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;As part of a PhD project I am currently &lt;b&gt;investigating the genetic background of canine IBD in German Shepherd Dogs (GSDs).&lt;/b&gt; In order to perform an adequately powered genomic scan as representative as possible of the UK population of this breed,&lt;b&gt; I am seeking to collect residual whole blood samples (1-2 ml) collected from GSDs during the diagnostic investigation of chronic GI signs which led to a diagnosis (endoscopic or surgical) of chronic enteropathy (food or antibiotic responsive diarrhoea and idiopathic IBD)&lt;/b&gt;. For the submission of the samples I would provide prepaid envelopes containing clients&amp;#39; consent form, project information form, clinical questionnaire. The project and the recruitment of samples from outside the RVC has received at priori ethical approval. Your help and support will be adequately aknowledged and very much appreciated!&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;If you are interested in supporting this project or if you have questions or doubts about the study please contact me directly at &lt;a  target='_blank'  href="mailto:fprocoli@rvc.ac.uk"&gt;&lt;span style="color:blue;"&gt;fprocoli@rvc.ac.uk&lt;/span&gt;&lt;/a&gt; and I will be happy to provide you with further details and advise you on how to submit the samples.&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;I thank you all in advance for your time and help and I look forward to hearing from you&lt;/span&gt;&lt;/b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;Ciao&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;Fabio&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;mso-margin-top-alt:auto;mso-margin-bottom-alt:auto;"&gt;&lt;b style="mso-bidi-font-weight:normal;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:Arial;"&gt;Fabio Procoli DMV,MVetMed, DipACVIM, MRCVS&lt;/span&gt;&lt;/b&gt;&lt;span style="font-family:&amp;#39;Arial&amp;#39;, &amp;#39;sans-serif&amp;#39;;color:black;font-size:9pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;PhD scholar&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;The Royal Veterinary College&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;Clinical Sciences and Services&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;Infection and Immunity Group&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;CEEED building&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;Hawkshead Lane&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;North Mymms&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;AL9 7TA&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;Herts, United Kingdom &lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-no-proof:yes;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;"&gt;&lt;/span&gt;&lt;span style="font-family:&amp;#39;Times New Roman&amp;#39;, &amp;#39;serif&amp;#39;;color:black;font-size:8pt;mso-fareast-font-family:&amp;#39;Times New Roman&amp;#39;;mso-fareast-language:EN-GB;mso-ansi-language:EN-GB;mso-bidi-language:AR-SA;"&gt;&lt;a  target='_blank'  href="mailto:fprocoli@rvc.ac.uk"&gt;&lt;span style="font-family:&amp;#39;Palatino Linotype&amp;#39;, &amp;#39;serif&amp;#39;;color:blue;mso-no-proof:yes;"&gt;fprocoli@rvc.ac.uk&lt;/span&gt;&lt;/a&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Idiopathic Pulmonary Fibrosis study</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1132/idiopathic-pulmonary-fibrosis-study</link><pubDate>Thu, 17 Jan 2013 16:54:29 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:dd960b5a-d79d-45af-99a8-cf21f6b640c6</guid><dc:creator>Sheena Warman</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Sheena Warman on 1/17/2013 4:54:29 PM&lt;br /&gt;
&lt;p&gt;Hello all&lt;/p&gt;
&lt;p&gt;Cecile Clercx, at the University of Liege, is recruiting cases of IPF for a research project which aims to investigate potential serum biomarkers to facilitate early diagnosis, understand the genetic background, and investigate the mechanisms of disease in the hope of identifying treatment targets.&amp;nbsp; Cecile needs to recruit as many dogs as possible for this study and would be keen to hear from any vets in first opinion or referral practice who think they might have a case.&amp;nbsp; Participation in the project requires some straightforward form-filling, and submission of any available blood and ideally lung samples (can be collected PM) to Liege.&amp;nbsp; There are some specific requirements for sample submission, so if you think you have a case then it is best to contact Cecile in advance and she can send you the information and sample pots.&amp;nbsp; &lt;/p&gt;
&lt;p&gt;Cecile&amp;#39;s email is &lt;a  target='_blank'  href="mailto:cclercx@ulg.ac.be"&gt;cclercx@ulg.ac.be&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;I&amp;#39;ve attempted to make a link to the vet information leaflet - &lt;a href="http://www.vetsurgeon.org/cfs-file.ashx/__key/CommunityServer.Wikis.Components.Files/b05484c7-fb69-4667-a724-ea71d67cc5db/8623.IPF-Vet-information-leaflet.pdf"&gt;www.vetsurgeon.org/.../8623.IPF-Vet-information-leaflet.pdf&lt;/a&gt; - let me know if it doesn&amp;#39;t work!&lt;/p&gt;
&lt;p&gt;Best wishes&lt;/p&gt;
&lt;p&gt;Sheena&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Winter meeting</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1125/winter-meeting</link><pubDate>Wed, 05 Sep 2012 10:27:36 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:28b490d2-69d5-49b8-9ba4-d5f9176edf78</guid><dc:creator>Alex Gough</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Alex Gough on 9/5/2012 10:27:36 AM&lt;br /&gt;
&lt;p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;Dear members&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;We are delighted to present the provisional plan and costs for the upcoming winter meeting.&amp;nbsp; Some of the finer details and topics will follow, however the outline is summarised below.&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;As many of you know we have been making efforts to meet at the end of the year.&amp;nbsp; The aim of this meeting is to try to develop collaborative research between our private practice and university-based members.&amp;nbsp; We have decided that this first meeting will take place on a single day.&amp;nbsp; The outline of the day is shown below.&amp;nbsp; We hope this will appeal to our membership, particularly those of you in first opinion practice who we are particularly keen on being involved in this venture.&amp;nbsp; As we all know there are so many crucial questions relating to cases we see every day that would be great to answer.&amp;nbsp; These questions will be so much easier to answer with collaboration.&amp;nbsp; We hope that with input from our members with expertise from first opinion practice and those active in research we will be able to generate projects that will make significant contributions to patients with common problems.&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;The outline for the inaugural meeting outline is as follows:&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;&lt;b&gt;Friday 23&lt;/b&gt;&lt;/span&gt;&lt;span class="s2"&gt;&lt;b&gt;&lt;sup&gt;rd&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class="s1"&gt;&lt;b&gt; November&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;Registration opens at 6pm &amp;ndash; till 8pm&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;Dinner 8.00-10.30pm &amp;ndash; venue TBC&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;&lt;b&gt;Saturday 24&lt;/b&gt;&lt;/span&gt;&lt;span class="s2"&gt;&lt;b&gt;&lt;sup&gt;th&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span class="s1"&gt;&lt;b&gt; November&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;8.00-9.00am Registration reopens&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;9.00am Welcome and introduction to the day&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;9.15am Overview of developing research collaborations with first opinion practice &amp;ndash; outlining the importance of first opinion case based research to attempt to address the current bias to referral populations in the literature.&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;10.00am Coffee (biscuits!) and discussion&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;10.30am Presentations by Protexin and Royal Canin on the current evidence for the use of probiotics and other neutraceuticals in dogs and cats&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;11.30am Presentation by the Pet Blood bank on current knowledge and future perspectives on the availability and use of blood products in dogs and cats&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;12.30am Case report and active research project presentations&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;1.30pm Lunch and discussion&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;2.30pm Review of projects proposed on the forum and new project proposals &amp;ndash; thoughts and ideas from membership. &amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p3"&gt;&lt;span class="s1"&gt;New project proposals to be presented in a 5 minute slot using 3 ppt slides or overheads, however visual aids not compulsory&lt;/span&gt;&lt;span class="s3"&gt;.&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;3.45pm Summary of project discussions from the afternoon &amp;ndash; proposals presented to rest of group with decision over which projects to take forwards and who will be involved in these.&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;4.00pm Coffee (biscuits!) and discussion&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;4.30pm Closing remarks and feedback&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;5.30pm Mentoring session for those keen on discussing projects with particular supervisors&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;The cost for the day has been fixed at &amp;pound;30 which will include lunch and registration fee.&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;&lt;b&gt;The venue is the School of Veterinary Medicine and Science, University of Nottingham, Sutton Bonington Campus, Leicestershire, LE12 5RD&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;We look forward to as many of you attending as possible.&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;Best wishes&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p1"&gt;&lt;span class="s1"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="p2"&gt;&lt;span class="s1"&gt;Mark on behalf of the organising committee&lt;/span&gt;&lt;/p&gt;
&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Minutes of AGM 2011</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1099/minutes-of-agm-2011</link><pubDate>Thu, 23 Feb 2012 14:07:15 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:8fd6c736-7c3b-41b8-8b3f-b9f038e8b100</guid><dc:creator>Alex Gough</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Alex Gough on 2/23/2012 2:07:15 PM&lt;br /&gt;
&lt;p&gt;Notes for Chairs report 2011&lt;/p&gt;
&lt;p&gt;1. Call AGM to order&lt;/p&gt;
&lt;p&gt;2. Apologies for absence&lt;/p&gt;
&lt;p&gt;David Walker, Alex German&lt;/p&gt;
&lt;p&gt;3. Chair&amp;rsquo;s report&lt;/p&gt;
&lt;p&gt;&amp;middot; Thank sponsors Hill&amp;rsquo;s (congress sponsor) Vetoquinol (case report sponsor) and Pfizer (travel scholarship sponsor).&lt;/p&gt;
&lt;p&gt;This is the last year for me (KM) to serve as Chair&lt;/p&gt;
&lt;p&gt;&amp;middot; The programme committee (Stijn, Sheena and Mark D) have done a great job and produced a great programme and David and Yvonne for sterling work advertising on listserve etc. Stijn had the job of physically carrying the heavy notes here.&lt;/p&gt;
&lt;p&gt;Yvonne particularly has done everyone&amp;rsquo;s jobs and has streamlined processes by making a task list for each committee role. &lt;/p&gt;
&lt;p&gt;Thanks to Mark M for work as treasurer (who would like to step down as he has a new business to take care of. He will stay on if the need arises).&lt;/p&gt;
&lt;p&gt;Thanks to Rebecca for sorting ICC it has certainly been more efficient, to Marge Chandler for organising notes even though now off committee, David W for PR &amp;ndash;increased awareness a lot though mail shots. Thanks to Allie W secretary who is also due to step down this year &amp;ndash; kept going through tricky family times. Also thanks to Allie&amp;rsquo;s hubby Jason who has previously audited accounts but now due to change in position in his real job will step aside but Allie offered to continue doing the auditing.&lt;/p&gt;
&lt;p&gt;Sheena is going to take the lead on programme&lt;/p&gt;
&lt;p&gt;We wish to have a new formal committee position to deal with the forum as this has previously been handled by Ian&lt;/p&gt;
&lt;p&gt;&amp;middot; Any ideas for next years programme we have been trying to offer a mix of topics &amp;ndash; please post any ideas on the on forum&lt;/p&gt;
&lt;p&gt;&amp;middot; Website /forum&amp;ndash; continue to encourage use of discussion forum, research trial advertising etc Ian Battersby has done some great work and the forum s being used well &amp;ndash; documents such as advertising research projects and new features features and minutes can be uploaded into wiki.&lt;/p&gt;
&lt;p&gt;&amp;middot; Antibiotic working group ( IB to comment on progress)&lt;/p&gt;
&lt;p&gt;&amp;middot; Constitution &amp;ndash; no changes recommended unless vote to lose 1st/2nd proposer. It was discussed and there was a majority in favour to stop new members having to be proposed and seconded by SAMSoc members. We will include a sentence in the constitution that allows a veto vote for members who are troublesome. IAB to action&lt;/p&gt;
&lt;p&gt;&amp;middot; Membership and finances to be covered by Yvonne and Mark&lt;/p&gt;
&lt;p&gt;&amp;middot; Longer term &amp;ndash; We wish the society to grow in size and have good meeting and attendance. We need to try to continue relationship with current sponsors, identify new sponsors, maintain case report prize &amp;ndash; great input again this year. Good interest in travel scholarship this year.&lt;/p&gt;
&lt;p&gt;Despite the meeting being run at a loss (mainly as a result of the expense of catering) we will increase cost of meeting to subsidise this. There was a majority vote for keeping lunch (lunch &amp;ndash; 23.80 + VAT/delegate and water is &amp;pound;1.50/delegate)&lt;/p&gt;
&lt;p&gt;&amp;middot; Encourage members to consider coming on committee if and when new members needed.&lt;/p&gt;
&lt;p&gt;4. Membership report&lt;/p&gt;
&lt;p&gt;136 members with 63 at meeting last year?&lt;/p&gt;
&lt;p&gt;This year 118 members, 25 were new members and 68 at 2011 meeting.&lt;/p&gt;
&lt;p&gt;Please let the membership secretary know if there is any change in email address.&lt;/p&gt;
&lt;p&gt;. &lt;/p&gt;
&lt;p&gt;5. Forum Report (Ian Battersby)&lt;/p&gt;
&lt;p&gt;120 people are active on the forum, with 200 discussions since forum started. Plea to members not to be afraid to have an opinion &amp;ndash; just disagree nicely!&lt;/p&gt;
&lt;p&gt;6. Treasurer&amp;rsquo;s report&lt;/p&gt;
&lt;p&gt;In 2010 there appears to be an improved profit, however that is because last years Hill&amp;rsquo;s sponsorship came in late.&lt;/p&gt;
&lt;p&gt;Members registered earlier for the meeting this year which was helpful.&lt;/p&gt;
&lt;p&gt;The bank balance total is financially sound.&lt;/p&gt;
&lt;p&gt;In 2010 the meeting made a loss of &amp;pound;3000 this was supported by &amp;pound;2000 sponsorship.&lt;/p&gt;
&lt;p&gt;Pfizer are committed to provision of &amp;pound;500 to be put towards the sponsorship of the antibiotic committee&amp;rsquo;s poster.&lt;/p&gt;
&lt;p&gt;b. KM thanked the treasurer&lt;/p&gt;
&lt;p&gt;7. Programme committee report by Stijn&lt;/p&gt;
&lt;p&gt;Took on board comments from last meeting, talks are now 45 mins long, Most members want a human speaker.&lt;/p&gt;
&lt;p&gt;It can be challenging to find speakers and to devise a programme so any ideas are welcomed please feedback via the vetsurgeon.org forum&lt;/p&gt;
&lt;p&gt;8. Antibiotic Committee report&lt;/p&gt;
&lt;p&gt;This is a small committee with a remit to produce empirical guidelines to moderate use of antibacterials/ provide useful suggestions. The aim was for it to be a poster but currently it is a 40 page document. There is planned a meeting with BSAVA to produce a draft later on the day of the satellite meeting. Ian Battersby to maintain updates.&lt;/p&gt;
&lt;p&gt;9. Election/reelection of committee members&lt;/p&gt;
&lt;p&gt;a. Anyone standing down &amp;ndash; if so we look to floor for volunteers &amp;amp; thank outgoing person&lt;/p&gt;
&lt;p&gt;Allie Woodward, Mark Maltman in 2011&lt;/p&gt;
&lt;p&gt;a) Vice - Chair &amp;ndash; Kate Murphy is standing down, however she has volunteered to stay on as Vice Chair and this was passed with a majority vote.&lt;/p&gt;
&lt;p&gt;b) Chair &amp;ndash; Majority vote for election of Ian Battersby (proposed by Allie Woodward and seconded by Mark Goodfellow&lt;/p&gt;
&lt;p&gt;c) Secretary &amp;ndash; Rebecca Littler has volunteered to take over role of Secretary and step down from her role as ICC liaison.&lt;/p&gt;
&lt;p&gt;d) Treasurer &amp;ndash; Mark Goodfellow proposed KM and Seconded IB&lt;/p&gt;
&lt;p&gt;e) Programme &amp;ndash; Stijn is at the end of his term but is happy to continue.&lt;/p&gt;
&lt;p&gt;f) Membership Secretary &amp;ndash; Yvonne is happy to continue and this was universally approved by vote.&lt;/p&gt;
&lt;p&gt;g) ICC Liaison &amp;ndash; Alison Collins proposer - KM and seconded - IB &lt;/p&gt;
&lt;p&gt;h) Forum &amp;ndash; Alex Gough proposed. KM seconded- IB&lt;/p&gt;
&lt;p&gt;10. Election of new members&lt;/p&gt;
&lt;p&gt;All new members were voted in en bloc&lt;/p&gt;
&lt;p&gt;&amp;nbsp;11.&amp;nbsp;&lt;span style="color:#000080;"&gt; &lt;span style="color:#000000;"&gt;Pfizer thanked but project was planned to proceed with bsava assistance without input necessary from external bodies. &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;12. Any other business&lt;/p&gt;
&lt;p&gt;a) vote on needing proposer/seconder when joining was discussed and it was agreed to remove this from the constitution and membership forms (action IAB and membership secretary). IAB will amend the constitution to allow committee veto if needed on a membership application, it is not expected that this would need to be considered often if ever&lt;/p&gt;
&lt;p&gt;b) vote on : notes format - paper or on usb (would need sponsorship of usb - or an increase in charge of subs) Plan to get feedback on this from forum. ACTION Sheena Warman&lt;/p&gt;
&lt;p&gt;c) vote on : should committee members pay registration for meeting (we do &lt;/p&gt;
&lt;p&gt;currently and have historically - all members to pay for this year). A majority vote agreed that committee members get free SAMSOC membership.&lt;/p&gt;
&lt;p&gt;d) Vote:- lunch to continue to be provided. Catering to be kept but cost of meeting will be increased to take this into account.&lt;/p&gt;
&lt;p&gt;e) Check everyone is aware record of attendance for CPD is within meeting notes.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;13. Incoming and welcome of the new Chair &amp;ndash; Ian Battersby who thanked Kate for all her hard work.&lt;/p&gt;
&lt;p&gt;14. Date of next meeting&lt;/p&gt;
&lt;p&gt;a. 11th April 2012&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Minutes of AGM 2011</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1099/minutes-of-agm-2011/revision/2</link><pubDate>Thu, 23 Feb 2012 13:29:01 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:8fd6c736-7c3b-41b8-8b3f-b9f038e8b100</guid><dc:creator>Alex Gough</dc:creator><description>Revision 2 posted to Small Animal Medicine Society by Alex Gough on 2/23/2012 1:29:01 PM&lt;br /&gt;
&lt;p&gt;Notes for Chairs report 2011&lt;/p&gt;
&lt;p&gt;1. Call AGM to order&lt;/p&gt;
&lt;p&gt;2. Apologies for absence&lt;/p&gt;
&lt;p&gt;David Walker, Alex German&lt;/p&gt;
&lt;p&gt;3. Chair&amp;rsquo;s report&lt;/p&gt;
&lt;p&gt;&amp;middot; Thank sponsors Hill&amp;rsquo;s (congress sponsor) Vetoquinol (case report sponsor) and Pfizer (travel scholarship sponsor).&lt;/p&gt;
&lt;p&gt;This is the last year for me (KM) to serve as Chair&lt;/p&gt;
&lt;p&gt;&amp;middot; The programme committee (Stijn, Sheena and Mark D) have done a great job and produced a great programme and David and Yvonne for sterling work advertising on listserve etc. Stijn had the job of physically carrying the heavy notes here.&lt;/p&gt;
&lt;p&gt;Yvonne particularly has done everyone&amp;rsquo;s jobs and has streamlined processes by making a task list for each committee role. &lt;/p&gt;
&lt;p&gt;Thanks to Mark M for work as treasurer (who would like to step down as he has a new business to take care of. He will stay on if the need arises).&lt;/p&gt;
&lt;p&gt;Thanks to Rebecca for sorting ICC it has certainly been more efficient, to Marge Chandler for organising notes even though now off committee, David W for PR &amp;ndash;increased awareness a lot though mail shots. Thanks to Allie W secretary who is also due to step down this year &amp;ndash; kept going through tricky family times. Also thanks to Allie&amp;rsquo;s hubby Jason who has previously audited accounts but now due to change in position in his real job will step aside but Allie offered to continue doing the auditing.&lt;/p&gt;
&lt;p&gt;Sheena is going to take the lead on programme&lt;/p&gt;
&lt;p&gt;We wish to have a new formal committee position to deal with the forum as this has previously been handled by Ian&lt;/p&gt;
&lt;p&gt;&amp;middot; Any ideas for next years programme we have been trying to offer a mix of topics &amp;ndash; please post any ideas on the on forum&lt;/p&gt;
&lt;p&gt;&amp;middot; Website /forum&amp;ndash; continue to encourage use of discussion forum, research trial advertising etc Ian Battersby has done some great work and the forum s being used well &amp;ndash; documents such as advertising research projects and new features features and minutes can be uploaded into wiki.&lt;/p&gt;
&lt;p&gt;&amp;middot; Antibiotic working group ( IB to comment on progress)&lt;/p&gt;
&lt;p&gt;&amp;middot; Constitution &amp;ndash; no changes recommended unless vote to lose 1st/2nd proposer. It was discussed and there was a majority in favour to stop new members having to be proposed and seconded by SAMSoc members. We will include a sentence in the constitution that allows a veto vote for members who are troublesome. IAB to action&lt;/p&gt;
&lt;p&gt;&amp;middot; Membership and finances to be covered by Yvonne and Mark&lt;/p&gt;
&lt;p&gt;&amp;middot; Longer term &amp;ndash; We wish the society to grow in size and have good meeting and attendance. We need to try to continue relationship with current sponsors, identify new sponsors, maintain case report prize &amp;ndash; great input again this year. Good interest in travel scholarship this year.&lt;/p&gt;
&lt;p&gt;Despite the meeting being run at a loss (mainly as a result of the expense of catering) we will increase cost of meeting to subsidise this. There was a majority vote for keeping lunch (lunch &amp;ndash; 23.80 + VAT/delegate and water is &amp;pound;1.50/delegate)&lt;/p&gt;
&lt;p&gt;&amp;middot; Encourage members to consider coming on committee if and when new members needed.&lt;/p&gt;
&lt;p&gt;4. Membership report&lt;/p&gt;
&lt;p&gt;136 members with 63 at meeting last year?&lt;/p&gt;
&lt;p&gt;This year 118 members, 25 were new members and 68 at 2011 meeting.&lt;/p&gt;
&lt;p&gt;Please let the membership secretary know if there is any change in email address.&lt;/p&gt;
&lt;p&gt;. &lt;/p&gt;
&lt;p&gt;5. Forum Report (Ian Battersby)&lt;/p&gt;
&lt;p&gt;120 people are active on the forum, with 200 discussions since forum started. Plea to members not to be afraid to have an opinion &amp;ndash; just disagree nicely!&lt;/p&gt;
&lt;p&gt;6. Treasurer&amp;rsquo;s report&lt;/p&gt;
&lt;p&gt;In 2010 there appears to be an improved profit, however that is because last years Hill&amp;rsquo;s sponsorship came in late.&lt;/p&gt;
&lt;p&gt;Members registered earlier for the meeting this year which was helpful.&lt;/p&gt;
&lt;p&gt;The bank balance total is financially sound.&lt;/p&gt;
&lt;p&gt;In 2010 the meeting made a loss of &amp;pound;3000 this was supported by &amp;pound;2000 sponsorship.&lt;/p&gt;
&lt;p&gt;Pfizer are committed to provision of &amp;pound;500 to be put towards the sponsorship of the antibiotic committee&amp;rsquo;s poster.&lt;/p&gt;
&lt;p&gt;b. KM thanked the treasurer&lt;/p&gt;
&lt;p&gt;7. Programme committee report by Stijn&lt;/p&gt;
&lt;p&gt;Took on board comments from last meeting, talks are now 45 mins long, Most members want a human speaker.&lt;/p&gt;
&lt;p&gt;It can be challenging to find speakers and to devise a programme so any ideas are welcomed please feedback via the vetsurgeon.org forum&lt;/p&gt;
&lt;p&gt;8. Antibiotic Committee report&lt;/p&gt;
&lt;p&gt;This is a small committee with a remit to produce empirical guidelines to moderate use of antibacterials/ provide useful suggestions. The aim was for it to be a poster but currently it is a 40 page document. There is planned a meeting with BSAVA to produce a draft later on the day of the satellite meeting. Ian Battersby to maintain updates.&lt;/p&gt;
&lt;p&gt;9. Election/reelection of committee members&lt;/p&gt;
&lt;p&gt;a. Anyone standing down &amp;ndash; if so we look to floor for volunteers &amp;amp; thank outgoing person&lt;/p&gt;
&lt;p&gt;Allie Woodward, Mark Maltman in 2011&lt;/p&gt;
&lt;p&gt;a) Vice - Chair &amp;ndash; Kate Murphy is standing down, however she has volunteered to stay on as Vice Chair and this was passed with a majority vote.&lt;/p&gt;
&lt;p&gt;b) Chair &amp;ndash; Majority vote for election of Ian Battersby (proposed by Allie Woodward and seconded by Mark Goodfellow&lt;/p&gt;
&lt;p&gt;c) Secretary &amp;ndash; Rebecca Littler has volunteered to take over role of Secretary and step down from her role as ICC liaison.&lt;/p&gt;
&lt;p&gt;d) Treasurer &amp;ndash; Mark Goodfellow proposed KM and Seconded IB&lt;/p&gt;
&lt;p&gt;e) Programme &amp;ndash; Stijn is at the end of his term but is happy to continue.&lt;/p&gt;
&lt;p&gt;f) Membership Secretary &amp;ndash; Yvonne is happy to continue and this was universally approved by vote.&lt;/p&gt;
&lt;p&gt;g) ICC Liaison &amp;ndash; Alison Collins proposer - KM and seconded - IB &lt;/p&gt;
&lt;p&gt;h) Forum &amp;ndash; Alex Gough proposed. KM seconded- IB&lt;/p&gt;
&lt;p&gt;10. Election of new members&lt;/p&gt;
&lt;p&gt;All new members were voted in en bloc&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;11. Any other business&lt;/p&gt;
&lt;p&gt;a) vote on needing proposer/seconder when joining was discussed and it was agreed to remove this from the constitution and membership forms (action IAB and membership secretary). IAB will amend the constitution to allow committee veto if needed on a membership application, it is not expected that this would need to be considered often if ever&lt;/p&gt;
&lt;p&gt;b) vote on : notes format - paper or on usb (would need sponsorship of usb - or an increase in charge of subs) Plan to get feedback on this from forum. ACTION Sheena Warman&lt;/p&gt;
&lt;p&gt;c) vote on : should committee members pay registration for meeting (we do &lt;/p&gt;
&lt;p&gt;currently and have historically - all members to pay for this year). A majority vote agreed that committee members get free SAMSOC membership.&lt;/p&gt;
&lt;p&gt;d) Vote:- lunch to continue to be provided. Catering to be kept but cost of meeting will be increased to take this into account.&lt;/p&gt;
&lt;p&gt;e) Check everyone is aware record of attendance for CPD is within meeting notes.&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;12. Incoming and welcome of the new Chair &amp;ndash; Ian Battersby who thanked Kate for all her hard work.&lt;/p&gt;
&lt;p&gt;13. Date of next meeting&lt;/p&gt;
&lt;p&gt;a. 11th April 2012&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Minutes of AGM 2011</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1099/minutes-of-agm-2011/revision/1</link><pubDate>Thu, 23 Feb 2012 13:27:22 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:8fd6c736-7c3b-41b8-8b3f-b9f038e8b100</guid><dc:creator>Alex Gough</dc:creator><description>Revision 1 posted to Small Animal Medicine Society by Alex Gough on 2/23/2012 1:27:22 PM&lt;br /&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;Notes for Chairs report 2011&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;1.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Call AGM to order&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;2.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Apologies for absence&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt 18pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;David Walker, Alex German&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;3.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Chair&amp;rsquo;s report&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Thank sponsors Hill&amp;rsquo;s (congress sponsor) Vetoquinol (case report sponsor) and Pfizer (travel scholarship sponsor).&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;This is the last year for me (KM) to serve as Chair&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;The programme committee (Stijn, Sheena and Mark D) have done a great job and produced a great programme and David and Yvonne for sterling work advertising on listserve etc. Stijn had the job of physically carrying the heavy notes here.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Yvonne particularly has done everyone&amp;rsquo;s jobs and has streamlined processes by making a task list for each committee role. &amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Thanks to Mark M for work as treasurer (who would like to step down as he has a new business to take care of. He will stay on if the need arises).&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Thanks to Rebecca for sorting ICC it has certainly been more efficient, to Marge Chandler for organising notes even though now off committee, David W for PR &amp;ndash;increased awareness a lot though mail shots. Thanks to Allie W secretary who is also due to step down this year &amp;ndash; kept going through tricky family times. Also thanks to Allie&amp;rsquo;s hubby Jason who has previously audited accounts but now due to change in position in his real job will step aside but Allie offered to continue doing the auditing.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Sheena is going to take the lead on programme&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;We wish to have a new formal committee position to deal with the forum as this has previously been handled by Ian&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Any ideas for next years programme we have been trying to offer a mix of topics &amp;ndash; please post any ideas on the on forum&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Website /forum&amp;ndash; continue to encourage use of discussion forum, research trial advertising etc Ian Battersby has done some great work and the forum s being used well &amp;ndash; documents such as advertising research projects and new features features and minutes can be uploaded into wiki.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Antibiotic working group ( IB to comment on progress)&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Constitution &amp;ndash; no changes recommended unless vote to lose 1&lt;sup&gt;st&lt;/sup&gt;/2&lt;sup&gt;nd&lt;/sup&gt; proposer. It was discussed and there was a majority in favour to stop new members having to be proposed and seconded by SAMSoc members.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;We will include a sentence in the constitution that allows a veto vote for members who are troublesome. IAB to action&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Membership and finances to be covered by Yvonne and Mark&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Longer term &amp;ndash; We wish the society to grow in size and have good meeting and attendance.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;We need to try to continue relationship with current sponsors, identify new sponsors, maintain case report prize &amp;ndash; great input again this year. Good interest in travel scholarship this year.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Despite the meeting being run at a loss (mainly as a result of the expense of catering) we will increase cost of meeting to subsidise this.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;There was a majority vote for keeping lunch (lunch &amp;ndash; 23.80 + VAT/delegate and water is &amp;pound;1.50/delegate)&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Symbol;mso-bidi-font-family:Symbol;"&gt;&amp;middot;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-family:Times New Roman;"&gt;Encourage members to consider coming on committee if and when new members needed.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;4.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Membership report&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;136 members with 63 at meeting last year?&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;This year 118 members, 25 were new members and 68 at 2011 meeting.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;Please let the membership secretary know if there is any change in email address.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;5.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Forum Report (Ian Battersby)&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;120 people are active on the forum, with 200 discussions since forum started.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;Plea to members not to be afraid to have an opinion &amp;ndash; just disagree nicely!&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;6.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Treasurer&amp;rsquo;s report&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;In 2010 there appears to be an improved profit, however that is because last years Hill&amp;rsquo;s sponsorship came in late.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Members registered earlier for the meeting this year which was helpful.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;The bank balance total is financially sound.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;In 2010 the meeting made a loss of &amp;pound;3000 this was supported by &amp;pound;2000 sponsorship.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Pfizer are committed to provision of &amp;pound;500 to be&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;put towards the sponsorship of the antibiotic committee&amp;rsquo;s poster.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;b.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;KM thanked the treasurer&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;7.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Programme committee report by Stijn&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;Took on board comments from last meeting, talks are now 45 mins long, Most members want a human speaker.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;It can be challenging to find speakers and to devise a programme so any ideas are welcomed please feedback via the vetsurgeon.org forum&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;8. &lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&amp;nbsp;&lt;/span&gt;Antibiotic Committee report&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;This is a small committee with a remit to produce empirical guidelines&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;to moderate use of antibacterials/ provide useful suggestions.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;The aim was for it to be a poster but currently it is a 40 page document.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;There is planned a meeting with BSAVA to produce a draft later on the day of the satellite meeting. Ian Battersby to maintain updates.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;9.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Election/reelection of committee members&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;a.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Anyone standing down &amp;ndash;&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;if so we look to floor for volunteers &amp;amp; thank outgoing person&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Allie Woodward, Mark Maltman in 2011&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;a)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Vice - Chair &amp;ndash; Kate Murphy is standing down, however she has volunteered to stay on as Vice Chair and this was passed with a majority vote.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;b)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Chair &amp;ndash; Majority vote for election of Ian Battersby (proposed by Allie Woodward and seconded by Mark Goodfellow&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;c)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Secretary &amp;ndash; Rebecca Littler has volunteered to take over role of Secretary and step down from her role as ICC liaison.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;d)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Treasurer &amp;ndash; Mark Goodfellow proposed KM and Seconded IB&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;e)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Programme &amp;ndash; Stijn is at the end of his term but is happy to continue.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;f)&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;Membership Secretary &amp;ndash; Yvonne is happy to continue and this was universally approved by vote.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;g)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;ICC Liaison &amp;ndash; Alison Collins proposer - KM and seconded - IB &amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;h)&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;Forum &amp;ndash; Alex Gough proposed. KM seconded- IB&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;10.&lt;span style="mso-tab-count:1;"&gt; &lt;/span&gt;Election of new members&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;All new members were voted in en bloc&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;11.&lt;span style="mso-tab-count:1;"&gt; &lt;/span&gt;Any other business&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&amp;nbsp;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;a) vote on needing proposer/seconder when joining was discussed and it was agreed to remove this from the constitution and membership forms (action&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;IAB and membership secretary). IAB will amend the constitution to allow committee veto if needed on a membership application, it is not expected that this would need to be considered often if ever&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;b) vote on : notes format - paper or on usb (would need sponsorship of usb - or an increase in charge of subs) Plan to get feedback on this from forum. ACTION Sheena Warman&lt;br /&gt;c) vote on : should committee members pay registration for meeting (we do &lt;br /&gt;currently and have historically - all members to pay for this year).&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;A majority vote agreed that committee members&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;get free SAMSOC membership.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;d) Vote:- lunch to continue to be provided. Catering to be kept but cost of meeting will be increased to take this into account.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;e) Check everyone is aware record of attendance for CPD is within meeting notes.&lt;br /&gt;&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:18pt;margin:0cm 0cm 0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;12.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;Incoming and welcome of the new Chair &amp;ndash; Ian Battersby who thanked Kate for all her hard work.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 36pt;tab-stops:36.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;13.&lt;span style="mso-tab-count:1;"&gt; &lt;/span&gt;Date of next meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-indent:-18pt;margin:0cm 0cm 0pt 72pt;tab-stops:72.0pt;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;a.&lt;span style="mso-tab-count:1;"&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/span&gt;11&lt;sup&gt;th&lt;/sup&gt; April 2012&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Exocrine Pancreatic insufficiency (EPI) Treatment Study </title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/82/exocrine-pancreatic-insufficiency-epi-treatment-study</link><pubDate>Thu, 26 Jan 2012 15:59:17 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:778f6079-166d-4353-8908-bb2cd3ca6a82</guid><dc:creator>Alex Gough</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Alex Gough on 1/26/2012 3:59:17 PM&lt;br /&gt;
&lt;p&gt;&lt;span&gt;&lt;b&gt;Exocrine Pancreatic insufficiency (EPI) Treatment Study&amp;nbsp;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;strong&gt;THIS STUDY IS NOW CLOSED TO FURTHER NEW SUBJECTS&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;Aran Mas DVM MRCVS&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;P-J.M.Noble BSc BVM&amp;amp;S PhD MRCVS,&amp;nbsp;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;A.J.German &lt;/span&gt;&lt;span&gt;BVSc PhD CertSAM DipECVIM-CA MRCVS&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;EPI is a common condition in dogs with early response to therapy being critical for positive outcomes (Batchelor et al, 2007). Pancreatic enzyme supplementation is the key component of therapy in EPI. Numerous enzyme preparations exist for use in dogs, some of which are enteric-coated and some uncoated.&amp;nbsp; Although one retrospective study on treatment of EPI suggested a better response with uncoated preparations (Hall et al., 1991), there was no difference in response amongst preparations in a more recent study (Batchelor et al., 2007).&amp;nbsp; However, prospective clinical trials, on treatment of EPI, are lacking.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;The Small Animal Teaching Hospital, University of Liverpool, is performing the first randomised double-blind trial to examine the effect of enteric coating on efficacy of pancreatic enzyme supplementation in the treatment of canine EPI. We are aiming to recruit dogs recently diagnosed with EPI for inclusion in this trial.&lt;b&gt; Enrolled patients will undergo clinical evaluation, two months of treatment and follow-up advice, all free of charge.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;b&gt;Inclusion criteria:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Clinical signs consistent with EPI (weight loss, poor weight gain, diarrhoea, polyphagia, coprophagia &lt;/li&gt;
&lt;li&gt;Serum trypsin-like immunoreactivity (TLI) measurement consistent with EPI &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;span&gt;&lt;b&gt;Exclusion criteria:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Animals with concurrent diseases that may affect the diagnosis, treatment or prognosis. The decision for exclusion of a particular case will rest with the investigator &lt;/li&gt;
&lt;li&gt;Cases that have not had routine haematology and&amp;nbsp; biochemistry analysis performed at the referring veterinary surgeon &lt;/li&gt;
&lt;li&gt;Cases with severe disease or debilitation, e.g. requiring hospitalisation and intensive management. However, such individuals may be suitable candidates once recovered &lt;/li&gt;
&lt;li&gt;Cases already on therapy for EPI &lt;/li&gt;
&lt;li&gt;Owners not willing to travel to the Small Animal Teaching Hospital for 4 consultations during the study period time (2 months)&amp;nbsp; &lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;If you have a suitable case and would like to discuss enrolment on the trial, please do not hesitate to contact us (telephone 0151 795 6100, &lt;a  target='_blank'  href="mailto:vetinmed@liv.ac.uk"&gt;&lt;span&gt;&lt;span style="color:#990000;"&gt;vetinmed@liv.ac.uk&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;)&lt;span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style="color:#222222;"&gt;References&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;BATCHELOR, D.J., NOBLE, P.J.M., CRIPPS, P.J., TAYLOR R., GERMAN, A.J. (2007) Prognostic factors in canine exocrine pancreatic insufficiency: prolonged survival is likely if clinical remission is achieved.&amp;nbsp; &lt;i&gt;Journal of Veterinary Internal Medicine&lt;/i&gt; &lt;b&gt;21&lt;/b&gt;; 54-60&lt;/p&gt;
&lt;p&gt;&lt;span&gt;HALL,&amp;nbsp; E.J., BOND, P.M., MCLEAN, C., BATT, RM, MCLEAN, L (1991) A survey of the diagnosis and treatment of canine exocrine pancreatic insufficiency.&amp;nbsp; &lt;i&gt;Journal of Small Animal Practice&lt;/i&gt; &lt;b&gt;32&lt;/b&gt;; 613&amp;ndash;619.&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Study into epileptoid cramping syndrome and Scottie Cramp</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1094/study-into-epileptoid-cramping-syndrome-and-scottie-cramp</link><pubDate>Thu, 26 Jan 2012 13:38:15 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:b5c4dee3-e9e4-45f8-bab3-b9021e3533b9</guid><dc:creator>Alex Gough</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Alex Gough on 1/26/2012 1:38:15 PM&lt;br /&gt;
&lt;div class="fpbody"&gt;
&lt;p&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;I am posting this on behalf of my colleague. Please see details below.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;We are seeking from colleagues cases of suspected canine epileptoid cramping syndrome in Border Terriers or of suspected Scottie cramp for the purpose of genetic research.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;Identification of a DNA marker for these conditions may help us to identify the cause of these disorders, accurately diagnose them and advise breeders in their breeding programs.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;A syndrome known as canine epileptoid cramping syndrome (also known as Spike&amp;rsquo;s disease) has been observed in Border Terriers. Episodes consist of gait abnormalities ranging from ataxia to an inability to stand, contractions of abdominal, neck and back muscles resulting in abnormal posturing and contractions/cramping of the appendicular muscle (extensor rigidity or flexion of the limbs). Duration of the episodes can vary from seconds to half an hour or longer during which the dog remains aware of his surrounding.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;Increased intestinal motility is suspected based on hearing borborygmus. Affected dogs may experience pain during the episodes.&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;Scottie cramp is a syndrome observed in young adult Scottish Terriers consisting of involuntary sustained muscle contractions primarily affecting the hind limbs. With excitement, the hind limbs assume a hypertonic, extended position or they may occasionally display exaggerated flexion of the limbs. The forelimbs become abducted and develop increased extensor tone. Affected dogs progressively develop a stiff stilted gait over a few minutes. Severely affected dogs assume an arched posture over their back and may fall into lateral recumbency with their head and tail flexed.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-family:Times New Roman;font-size:small;"&gt;&lt;span style="font-size:x-small;"&gt;If you have a case of suspected canine epileptoid cramping syndrome or of suspected Scottie cramp, please contact Dr Laurent Garosi at Davies Veterinary Specialists (&lt;/span&gt;&lt;/span&gt;&lt;a  target='_blank'  href="mailto:lsg@vetspecialists.co.uk"&gt;&lt;span style="font-family:Times New Roman;font-size:small;"&gt;&lt;span style="color:#990000;font-size:x-small;"&gt;lsg@vetspecialists.co.uk&lt;/span&gt;&lt;/span&gt;&lt;/a&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt; or telephone 01582 883950).&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-family:Times New Roman;font-size:small;"&gt;&lt;span style="font-size:x-small;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-size:x-small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;Dr Laurent S Garosi DVM, MRCVS, Dip ECVN &amp;ndash; Head of neurology/neurosurgery - Davies Veterinary Specialists, Higham Gobion, England&lt;/span&gt; &lt;/span&gt;&lt;/span&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-family:Times New Roman;font-size:small;"&gt;&lt;span style="font-size:x-small;"&gt;&amp;nbsp;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;Prof Robert J Harvey BSc, PhD &amp;ndash; Professor of Molecular Neuroscience and Genetics, Department of Pharmacology, UCL School of Pharmacy, 29-39 Brunswick Square, London, England&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p class="MsoNormal" style="margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:small;"&gt;&lt;span style="font-family:Times New Roman;"&gt;&lt;span style="font-size:x-small;"&gt;Mark Lowrie&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;&lt;span style="font-size:x-small;"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;div style="clear:both;"&gt;&lt;span style="font-size:x-small;"&gt;&lt;/span&gt;&lt;/div&gt;
&lt;div class="fpsig"&gt;
&lt;p&gt;MA VetMB MVM DipECVN MRCVS&lt;br /&gt;European Specialist in&amp;nbsp;Veterinary Neurology&lt;br /&gt;Davies Veterinary Specialists,&amp;nbsp;Herts UK. &lt;a  target='_blank'  target="_blank" href="http://www.vetspecialists.co.uk/"&gt;&lt;span style="color:#990000;"&gt;www.vetspecialists.co.uk&lt;/span&gt;&lt;/a&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;/p&gt;
&lt;p class="MsoNormal" style="text-align:justify;margin:0cm 0cm 0pt;"&gt;&lt;span style="color:black;"&gt;&lt;span style="font-size:x-small;"&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/div&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>SAMSoc Committee roles</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/1026/samsoc-committee-roles</link><pubDate>Wed, 23 Feb 2011 22:02:13 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:86801f23-1482-423e-b4ec-2091f95d9cb6</guid><dc:creator>Kate Murphy</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Kate Murphy on 2/23/2011 10:02:13 PM&lt;br /&gt;
&lt;p align="center" style="margin:0cm 0cm 10pt;text-align:center;" class="MsoNormal"&gt;&lt;b style="mso-bidi-font-weight:normal;"&gt;&lt;span style="text-decoration:underline;"&gt;&lt;span style="font-size:14pt;line-height:115%;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;SAMSoc Duties&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;table border="1" cellpadding="0" cellspacing="0" style="border-collapse:collapse;mso-border-alt:solid black .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0cm 5.4pt 0cm 5.4pt;mso-border-insideh:.5pt solid black;mso-border-insidev:.5pt solid black;" class="MsoNormalTable"&gt;
&lt;tbody&gt;
&lt;tr style="mso-yfti-irow:0;mso-yfti-firstrow:yes;"&gt;
&lt;td width="237" valign="top" style="padding-right:5.4pt;padding-left:5.4pt;padding-bottom:0cm;width:177.5pt;padding-top:0cm;background-color:transparent;mso-border-alt:solid black .5pt;border:black 1pt solid;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;b style="mso-bidi-font-weight:normal;"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Action&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:black 1pt solid;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;b style="mso-bidi-font-weight:normal;"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Person Responsible&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:black 1pt solid;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;b style="mso-bidi-font-weight:normal;"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Due Date&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:1;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Update Website&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;PR&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;All year&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Particular emphasis around Autumn and Jan/Feb to advertise meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:2;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Authorise new members &amp;amp; respond to all enquiries&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;All year&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:3;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Sponsorship for meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Treasurer (or delegated to committee member with personal contact - however treasurer remains responsible for ensuring it is done)&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p style="margin:0cm 0cm 0pt;line-height:normal;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Contact sponsors after last meeting to thank them and investigate if willing to continue.&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin:0cm 0cm 0pt;line-height:normal;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Contact with final programme as soon as is available&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="margin:0cm 0cm 0pt;line-height:normal;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Contact before catering deadline to find out requirements of sponsors for lunch, and double check requirements on day &amp;ndash; let ICC liaison person know&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:4;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Room allocation at ICC&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;ICC Liaison&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;September&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:5;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Decide on topics for meeting &amp;amp; approach speakers&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Programme Committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p style="margin:0cm 0cm 0pt;line-height:normal;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Start as soon as BSAVA release programme with deadline for October&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:6;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Finalise speakers and produce Programme for day&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Programme committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;October-November&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:7;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Advertise case report sessions&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Programme committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;November, monthly reminders till deadline&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:8;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Advertise travel scholarship&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;PR&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;October-December&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:9;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Request payment for subs&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Treasurer/membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;January-April&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:10;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Send receipts for subs&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;January-April&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:11;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Request payment for meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;January-April&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:12;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Send receipts for meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;January-April&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:13;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Maintain database of members&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;January-April&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:14;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Advertise meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary and PR&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;October-April&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:15;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Liaise with ICC regarding layout/hall/badges&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;ICC&lt;span style="mso-spacerun:yes;"&gt;&amp;nbsp; &lt;/span&gt;Liaison&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Jan-March&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:16;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Finalise case report session&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Programme committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;March&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:17;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Finalise programme &amp;amp; update on website&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Programme committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;November-March&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:18;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Pay ICC Invoice&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Treasurer&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;March&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:19;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Finalise catering with ICC&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;ICC Liaison&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;March&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:20;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Advertise AGM via website&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary and PR&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;February&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:21;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Review constitution&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Chairperson&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;At least every March&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:22;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Prepare notes for meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary in liaison with programme committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;3 weeks prior to meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:23;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;CPD Record of attendance&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary in liaison with Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;3 weeks prior to meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:24;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Collate list of delegates&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;1 week prior to meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:25;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Print names on badges&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary in liaison with Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;1 week prior to meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:26;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Registration&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary/ membership Secretary and others&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;At meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:27;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Chairing at meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Chairperson and others from programme committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;At meeting&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:28;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Minutes of AGM&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Take minutes at meeting, produce coherent record within 1 month of meeting to be posted on website after Chairperson agrees them&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:29;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Remove members that have not paid subs from website&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Membership secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;May&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:30;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Consider ways to grow society&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Chairperson&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;PR&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;All&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;All year&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:31;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Ensure everything stays on track&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Chairperson&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;All year&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:32;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Ensure BSAVA has correct contacts for Committee&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;After each AGM&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:33;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Maintain affiliated group membership&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Secretary&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;After each AGM&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;tr style="mso-yfti-irow:34;mso-yfti-lastrow:yes;"&gt;
&lt;td width="237" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:black 1pt solid;width:177.5pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-family:Calibri;"&gt;&lt;span style="font-size:14pt;color:black;mso-ansi-language:EN-GB;mso-bidi-font-family:&amp;#39;Comic Sans MS&amp;#39;;mso-fareast-language:EN-GB;"&gt;Maintain books of accounts, banking, pay all invoices, prepare end of year accounts&lt;/span&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="191" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:143.1pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;Treasurer&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;td width="211" valign="top" style="border-right:black 1pt solid;padding-right:5.4pt;border-top:#ece9d8;padding-left:5.4pt;padding-bottom:0cm;border-left:#ece9d8;width:158.2pt;padding-top:0cm;border-bottom:black 1pt solid;background-color:transparent;mso-border-alt:solid black .5pt;mso-border-left-alt:solid black .5pt;mso-border-top-alt:solid black .5pt;"&gt;
&lt;p align="center" style="margin:0cm 0cm 0pt;line-height:normal;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;mso-ansi-language:EN-GB;"&gt;&lt;span style="font-family:Calibri;"&gt;All year&amp;lt;o:p&amp;gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p align="center" style="margin:0cm 0cm 10pt;text-align:center;" class="MsoNormal"&gt;&lt;span style="font-size:14pt;line-height:115%;mso-ansi-language:EN-GB;"&gt;&amp;lt;o:p&amp;gt;&lt;span style="font-family:Calibri;"&gt;&amp;nbsp;&lt;/span&gt;&amp;lt;/o:p&amp;gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Efficacy of Protexin Pro-Kolin Enterogenic in conjunction with ronidazole in the treatment of T.foetus in cats with diarrhoea</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/966/efficacy-of-protexin-pro-kolin-enterogenic-in-conjunction-with-ronidazole-in-the-treatment-of-t-foetus-in-cats-with-diarrhoea</link><pubDate>Fri, 04 Feb 2011 10:03:34 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:4a097497-5208-4501-8ccc-26230c0037e9</guid><dc:creator>Ian Battersby</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Ian Battersby on 2/4/2011 10:03:34 AM&lt;br /&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;A study is underway to evaluate the efficacy of Protexin Pro-Kolin Enterogenic in conjunction with ronidazole in the treatment of T.foetus in cats with diarrhoea. Referring vets who have diagnosed T.foetus by PCR are asked to contact Professor Danielle Gunn-Moore or Stephanie Lalor at University of Edinburgh Hospital for Small Animals using the contact details below to discuss enrolment of cats into the study.&lt;br /&gt;&lt;br /&gt;Tel. 0131 650 7650&lt;br /&gt;Email. &lt;a href="http://www.vetsurgeon.org/imp/compose.php?to=slalor%40staffmail.ed.ac.uk" title="http://www.vetsurgeon.org/imp/compose.php?to=slalor%40staffmail.ed.ac.uk"&gt;slalor@staffmail.ed.ac.uk&lt;/a&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Minutes of SAMSoc AGM 2010</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/965/minutes-of-samsoc-agm-2010</link><pubDate>Thu, 03 Feb 2011 07:52:47 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:23315eb0-1bcd-473f-82b0-40519bace7ef</guid><dc:creator>Allie Woodward</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Allie Woodward on 2/3/2011 7:52:47 AM&lt;br /&gt;
&lt;p&gt;&lt;span style="font-size:x-small;"&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;MINUTES OF SAMSoc AGM 2010&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="font-size:x-small;"&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style="text-decoration:underline;"&gt;Apologies&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Clive Elwood, Mark Maltman, Marge Chandler, Rebecca Littler&lt;/p&gt;
&lt;p&gt;We would like to congratulate Rebecca Littler on the birth of her baby.&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Chairmans Report&lt;/span&gt;&lt;/p&gt;
&lt;span lang="EN"&gt;
&lt;p&gt;Thanks to our sponsors Hill&lt;/p&gt;
&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;&lt;span lang="EN"&gt;s and Vetoquinol.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Thanks to our Programme committee Stijn, Sheena, and Marge Chandler. It is difficult to provide a varied and generalised programme that is suitable for both specialists and generalists.&lt;/p&gt;
&lt;p&gt;Other members of the committee are very hard working in particular Ian Battersby and Yvonne McGrotty who have performed sterling work on advertising on list serve and setting up the forum with Arlo Guthrie of Vetsurgeon.org.&lt;/p&gt;
&lt;p&gt;We would like to to encourage our members to make use of the discussion forum and log on regularly as there are additional features such as the online research trial and job advertisements.&lt;/p&gt;
&lt;p&gt;Any members who have not paid their subs by the end of April will be removed from the online forum by Yvonne.&lt;/p&gt;
&lt;p&gt;Ian Battersby is invited to discuss the Antibiotic Working Group. See appended section&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Constitution&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;The committee is elected for 3 years and members may be re-elected for a further 3 years.&lt;/p&gt;
&lt;p&gt;We extend our thanks to Clive Elwood who is stepping down this year as he resurrected the society and also produced a constitution. We thought that a gift for his dedication was in order so we are sending him for a Tank Driving Experience Day. He has sent an email to thank us for this.&lt;/p&gt;
&lt;p&gt;We would also like to thank Marge Chandler for her hard work with the Programme, She will continue to print the meeting notes if required.&lt;/p&gt;
&lt;p&gt;We would like to encourage members to consider coming on to the committee when new committee members are needed. Next year we will be needing a new Chair person and Ian Battersby is up to be re-elected next year.&lt;/p&gt;
&lt;p&gt;Yvonne will be drawing up a list of the duties of each committee member (as she has worked very hard and has done a little of everyones jobs this year).&lt;/p&gt;
&lt;p&gt;In the longer term our aims should be to continue our relationship with our current sponsors., identify new sponsors and maintain the case report prize which had great input this year.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Membership Secretary&lt;/p&gt;
&lt;/span&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s report&lt;/span&gt;&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;The group has 116 members with 100 members registered on the vetsurgeon.org forum. &lt;/p&gt;
&lt;p&gt;There are 63 members attending this meeting.&lt;/p&gt;
&lt;p&gt;Please join the web forum&lt;/p&gt;
&lt;p&gt;Subs are due and should be paid at the time we are paying for the PreBSAVA satellite meeting.&lt;/p&gt;
&lt;p&gt;There was majority agreement that it should be paid for all in one sum. Although access to web forum will be restricted to subscribed members only.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Treasurers Report:- Summary&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;We would like to thank the Treasurer and Dr. Jason Woodward for compiling and auditing the accounts respectively.&lt;/p&gt;
&lt;p&gt;In 2009 the society made a profit but it was less than appearences would seem as we had to bank 2 years worth of Hill&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt; &lt;span lang="EN"&gt;s sponsorship (and they are thanked for that). Therefore the corrected profit for 2009 was somewhat less that the profit in 2008.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;The loss for the 2009 meeting was just over &amp;pound;1000 greater than in 2008 but if we take member subscriptions and sponsorship into account we do break even.&lt;/p&gt;
&lt;p&gt;The major cost to the society is catering and the cost of the meeting was an extra &amp;pound;800 this year.&lt;/p&gt;
&lt;p&gt;We will investigate the cost of a cold stand up buffet to see if catering costs can be reduced.&lt;/p&gt;
&lt;p&gt;Obviously bank interest is very low at present so not giving a significant income. &lt;/p&gt;
&lt;p&gt;We currently have 144 members and 100 members enrolled on vetsurgeon.org forum&lt;/p&gt;
&lt;p&gt;　&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Election of Committee members&lt;/p&gt;
&lt;/span&gt;&lt;b&gt;
&lt;p&gt;&lt;em&gt;Vice Chair&lt;/em&gt;:- &lt;/p&gt;
&lt;/b&gt;
&lt;p&gt;IB is to deal with the forum &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;Programme committee:- Mark Dunning&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;em&gt;PR&lt;/em&gt;;- David Walker&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;Re-election&lt;/p&gt;
&lt;/b&gt;
&lt;p&gt;The Post of Vice Chair was not refilled.&lt;/p&gt;
&lt;p&gt;Rebecca Littler (ICC liason) , Ian Battersby (to deal with the forum) and Allie Woodward (secretary) were reelected onto the committee.&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;New Members of SAMSoc&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;There was unanimous approval of a block vote of new members of the society.&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Programme committee report by Stijn Nielsson&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Feedback from 2009 meeting&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Largely positive with a mix of comments on a mixture of topics. With trends. Generally the case reports were very positively received. Some people had the opinion that the case reports shortened the time available for the lectures, and whether members would like to increase the number of case reports.&lt;/p&gt;
&lt;p&gt;Some members prefer the day to focus on a single topic area others would prefer a mixture. Obviously this variation in opinion cannot be wholly fulfilled and this year we opted for a mixture of talks with a trend in the thromoboembolism theme. &lt;/p&gt;
&lt;p&gt;This year the room is hot, whereas last year it was cold!&lt;/p&gt;
&lt;p&gt;Human speakers appear to provide shorter summary lecture notes than their veterinary counterparts.&lt;/p&gt;
&lt;p&gt;Please would members give feedback on this years meeting .. It may be possible to put a poll on vetsurgeon.org. regarding the interactive case reports.&lt;/p&gt;
&lt;p&gt;Travel Scholarship - this should be attractive benefit for membership not advertised well. Another incentive to get on forum and the price of entering for the scholarship is to provide a written piece on the travel undertaken. This report could be published in the veterinary Times would give publicity for the society. It would be interesting to gain insights as to what the value of the travel scholarship should be.&lt;/p&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Kate Murphy is reconsidering the membership structure and looking at access to RCVS library - Mark Dunning pointed out that there had been a reduction in the number of journals offered in their archives.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;　&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;ANTIBIOTIC Working Group　&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;IB:- The Antibiotic Working group has been set up to try to come up with a poster of guidelines for the use of antibiotics in some clinical situations. Progress has been slow initially. It is a large project and we hope to back it up with information. The BSAVA Scientific committee is backing this project and possibly we will produce a back up document. Likely it will be a 2 year project and may not cover all situations. The hope is that general practitioners will use the guidelines and prevent the restrictions to antibiotic use that were described in Sue Dawson&lt;/span&gt;&lt;/p&gt;
&lt;span style="text-decoration:underline;"&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt; &lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;&lt;span style="text-decoration:underline;"&gt;s lecture.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:x-small;"&gt;&lt;span style="font-size:x-small;"&gt;&lt;span lang="EN-GB"&gt;&lt;span style="text-decoration:underline;"&gt; &lt;/span&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;The length of the lectures are to be changed to 45 minutes per lecture. 　&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Date of next meetingWednesday 30&lt;sup&gt;th&lt;/sup&gt; March, 2011&lt;/span&gt;&lt;/p&gt;
&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang="EN-GB"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Any Other Business&lt;/span&gt;&lt;/p&gt;
&lt;/b&gt;&lt;/b&gt;&lt;span style="text-decoration:underline;"&gt;:-&lt;/span&gt;&lt;/b&gt;&lt;/b&gt;.&lt;/b&gt;&lt;/b&gt;David Walker was unanimously voted into the PR role.&lt;/b&gt;Mark Dunning was unanimously voted as a member of programme committee.&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Minutes of SAMSoc AGM 2010</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/965/minutes-of-samsoc-agm-2010/revision/2</link><pubDate>Thu, 03 Feb 2011 07:43:08 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:23315eb0-1bcd-473f-82b0-40519bace7ef</guid><dc:creator>Allie Woodward</dc:creator><description>Revision 2 posted to Small Animal Medicine Society by Allie Woodward on 2/3/2011 7:43:08 AM&lt;br /&gt;
&lt;p&gt;&lt;span style="font-size:x-small;"&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;span style="font-size:x-small;"&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style="text-decoration:underline;"&gt;Apologies&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Clive Elwood, Mark Maltman, Marge Chandler, Rebecca Littler&lt;/p&gt;
&lt;p&gt;We would like to congratulate Rebecca Littler on the birth of her baby.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Chairmans Report&lt;/p&gt;
&lt;/span&gt;&lt;span lang="EN"&gt;
&lt;p&gt;Thanks to our sponsors Hill&lt;/p&gt;
&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;/span&gt;&lt;span lang="EN"&gt;&lt;span style="text-decoration:underline;"&gt;&lt;strong&gt;SAMSoc Committee Meeting AGM April 2010.&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s and Vetoquinol.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Thanks to our Programme committee Stijn, Sheena, and Marge Chandler. It is difficult to provide a varied and generalised programme that is suitable for both specialists and generalists.&lt;/p&gt;
&lt;p&gt;Other members of the committee are very hard working in particular Ian Battersby and Yvonne McGrotty who have performed sterling work on advertising on list serve and setting up the forum with Arlo Guthrie of Vetsurgeon.org.&lt;/p&gt;
&lt;p&gt;We would like to to encourage our members to make use of the discussion forum and log on regularly as there are additional features such as the online research trial and job advertisements.&lt;/p&gt;
&lt;p&gt;Any members who have not paid their subs by the end of April will be removed from the online forum by Yvonne.&lt;/p&gt;
&lt;p&gt;Ian Battersby is invited to discuss the Antibiotic Working Group. See appended section&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Constitution&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;The committee is elected for 3 years and members may be re-elected for a further 3 years.&lt;/p&gt;
&lt;p&gt;We extend our thanks to Clive Elwood who is stepping down this year as he resurrected the society and also produced a constitution. We thought that a gift for his dedication was in order so we are sending him for a Tank Driving Experience Day. He has sent an email to thank us for this.&lt;/p&gt;
&lt;p&gt;We would also like to thank Marge Chandler for her hard work with the Programme, She will continue to print the meeting notes if required.&lt;/p&gt;
&lt;p&gt;We would like to encourage members to consider coming on to the committee when new committee members are needed. Next year we will be needing a new Chair person and Ian Battersby is up to be re-elected next year.&lt;/p&gt;
&lt;p&gt;Yvonne will be drawing up a list of the duties of each committee member (as she has worked very hard and has done a little of everyones jobs this year).&lt;/p&gt;
&lt;p&gt;In the longer term our aims should be to continue our relationship with our current sponsors., identify new sponsors and maintain the case report prize which had great input this year.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Membership Secretary&lt;/p&gt;
&lt;/span&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s report&lt;/span&gt;&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;The group has 116 members with 100 members registered on the vetsurgeon.org forum. &lt;/p&gt;
&lt;p&gt;There are 63 members attending this meeting.&lt;/p&gt;
&lt;p&gt;Please join the web forum&lt;/p&gt;
&lt;p&gt;Subs are due and should be paid at the time we are paying for the PreBSAVA satellite meeting.&lt;/p&gt;
&lt;p&gt;There was majority agreement that it should be paid for all in one sum. Although access to web forum will be restricted to subscribed members only.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Treasurers Report:- Summary&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;We would like to thank the Treasurer and Dr. Jason Woodward for compiling and auditing the accounts respectively.&lt;/p&gt;
&lt;p&gt;In 2009 the society made a profit but it was less than appearences would seem as we had to bank 2 years worth of Hill&lt;/p&gt;
&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s sponsorship (and they are thanked for that). Therefore the corrected profit for 2009 was somewhat less that the profit in 2008.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;The loss for the 2009 meeting was just over &amp;pound;1000 greater than in 2008 but if we take member subscriptions and sponsorship into account we do break even.&lt;/p&gt;
&lt;p&gt;The major cost to the society is catering and the cost of the meeting was an extra &amp;pound;800 this year.&lt;/p&gt;
&lt;p&gt;We will investigate the cost of a cold stand up buffet to see if catering costs can be reduced.&lt;/p&gt;
&lt;p&gt;Obviously bank interest is very low at present so not giving a significant income. &lt;/p&gt;
&lt;p&gt;We currently have 144 members and 100 members enrolled on vetsurgeon.org forum&lt;/p&gt;
&lt;p&gt;　&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Election of Committee members&lt;/p&gt;
&lt;/span&gt;&lt;b&gt;
&lt;p&gt;Vice Chair:- &lt;/p&gt;
&lt;/b&gt;
&lt;p&gt;IB is to deal with the forum &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;Programme committee:- &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;PR;- &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;Re-election&lt;/p&gt;
&lt;/b&gt;
&lt;p&gt;The Post of Vice Chair was not refilled.&lt;/p&gt;
&lt;p&gt;Rebecca Littler (ICC liason) , Ian Battersby (to deal with the forum) and Allie Woodward (secretary) were reelected onto the committee.&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;New Members of SAMSoc&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;There was unanimous approval of a block vote of new members of the society.&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Programme committee report by Stijn Nielsson&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Feedback from 2009 meeting&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Largely positive with a mix of comments on a mixture of topics. With trends. Generally the case reports were very positively received. Some people had the opinion that the case reports shortened the time available for the lectures, and whether members would like to increase the number of case reports.&lt;/p&gt;
&lt;p&gt;Some members prefer the day to focus on a single topic area others would prefer a mixture. Obviously this variation in opinion cannot be wholly fulfilled and this year we opted for a mixture of talks with a trend in the thromoboembolism theme. &lt;/p&gt;
&lt;p&gt;This year the room is hot, whereas last year it was cold!&lt;/p&gt;
&lt;p&gt;Human speakers appear to provide shorter summary lecture notes than their veterinary counterparts.&lt;/p&gt;
&lt;p&gt;Please would members give feedback on this years meeting .. It may be possible to put a poll on vetsurgeon.org. regarding the interactive case reports.&lt;/p&gt;
&lt;p&gt;Travel Scholarship - this should be attractive benefit for membership not advertised well. Another incentive to get on forum and the price of entering for the scholarship is to provide a written piece on the travel undertaken. This report could be published in the veterinary Times would give publicity for the society. It would be interesting to gain insights as to what the value of the travel scholarship should be.&lt;/p&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Kate Murphy is reconsidering the membership structure and looking at access to RCVS library - Mark Dunning pointed out that there had been a reduction in the number of journals offered in their archives.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;　&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;ANTIBIOTIC Working Group　&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;IB:- The Antibiotic Working group has been set up to try to come up with a poster of guidelines for the use of antibiotics in some clinical situations. Progress has been slow initially. It is a large project and we hope to back it up with information. The BSAVA Scientific committee is backing this project and possibly we will produce a back up document. Likely it will be a 2 year project and may not cover all situations. The hope is that general practitioners will use the guidelines and prevent the restrictions to antibiotic use that were described in Sue Dawson&lt;/span&gt;&lt;/p&gt;
&lt;span style="text-decoration:underline;"&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt; &lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;&lt;span style="text-decoration:underline;"&gt;s lecture.&lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:x-small;"&gt;&lt;span style="font-size:x-small;"&gt;&lt;span lang="EN-GB"&gt;&lt;span style="text-decoration:underline;"&gt; &lt;/span&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;The length of the lectures are to be changed to 45 minutes per lecture. 　&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Date of next meetingWednesday 30&lt;sup&gt;th&lt;/sup&gt; March, 2011&lt;/span&gt;&lt;/p&gt;
&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang="EN-GB"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;
&lt;p&gt;&lt;span style="text-decoration:underline;"&gt;Any Other Business&lt;/span&gt;&lt;/p&gt;
&lt;/b&gt;&lt;/b&gt;&lt;span style="text-decoration:underline;"&gt;:-&lt;/span&gt;&lt;/b&gt;&lt;/b&gt;.&lt;/b&gt;&lt;/b&gt;David Walker was unanimously voted into the PR role.&lt;/b&gt;Mark Dunning was unanimously voted as a member of programme committee.&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Minutes of SAMSoc AGM 2010</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/965/minutes-of-samsoc-agm-2010/revision/1</link><pubDate>Thu, 03 Feb 2011 07:22:54 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:23315eb0-1bcd-473f-82b0-40519bace7ef</guid><dc:creator>Allie Woodward</dc:creator><description>Revision 1 posted to Small Animal Medicine Society by Allie Woodward on 2/3/2011 7:22:54 AM&lt;br /&gt;
&lt;p&gt;&lt;span style="font-size:x-small;"&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;&lt;span lang="EN"&gt;
&lt;p align="center"&gt;&lt;span style="text-decoration:underline;"&gt;&lt;strong&gt;SAMSoc Committee Meeting AGM April 2010.&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
&lt;span style="font-size:x-small;"&gt;
&lt;p&gt;&lt;strong&gt;&lt;span style="text-decoration:underline;"&gt;Apologies&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Clive Elwood, Mark Maltman, Marge Chandler, Rebecca Littler&lt;/p&gt;
&lt;p&gt;We would like to congratulate Rebecca Littler on the birth of her baby.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Chairmans Report&lt;/p&gt;
&lt;/span&gt;&lt;span lang="EN"&gt;
&lt;p&gt;Thanks to our sponsors Hill&lt;/p&gt;
&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s and Vetoquinol.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Thanks to our Programme committee Stijn, Sheena, and Marge Chandler. It is difficult to provide a varied and generalised programme that is suitable for both specialists and generalists.&lt;/p&gt;
&lt;p&gt;Other members of the committee are very hard working in particular Ian Battersby and Yvonne McGrotty who have performed sterling work on advertising on list serve and setting up the forum with Arlo Guthrie of Vetsurgeon.org.&lt;/p&gt;
&lt;p&gt;We would like to to encourage our members to make use of the discussion forum and log on regularly as there are additional features such as the online research trial and job advertisements.&lt;/p&gt;
&lt;p&gt;Any members who have not paid their subs by the end of April will be removed from the online forum by Yvonne.&lt;/p&gt;
&lt;p&gt;Ian Battersby is invited to discuss the Antibiotic Working Group. See appended section&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Constitution&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;The committee is elected for 3 years and members may be re-elected for a further 3 years.&lt;/p&gt;
&lt;p&gt;We extend our thanks to Clive Elwood who is stepping down this year as he resurrected the society and also produced a constitution. We thought that a gift for his dedication was in order so we are sending him for a Tank Driving Experience Day. He has sent an email to thank us for this.&lt;/p&gt;
&lt;p&gt;We would also like to thank Marge Chandler for her hard work with the Programme, She will continue to print the meeting notes if required.&lt;/p&gt;
&lt;p&gt;We would like to encourage members to consider coming on to the committee when new committee members are needed. Next year we will be needing a new Chair person and Ian Battersby is up to be re-elected next year.&lt;/p&gt;
&lt;p&gt;Yvonne will be drawing up a list of the duties of each committee member (as she has worked very hard and has done a little of everyones jobs this year).&lt;/p&gt;
&lt;p&gt;In the longer term our aims should be to continue our relationship with our current sponsors., identify new sponsors and maintain the case report prize which had great input this year.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Membership Secretary&lt;/p&gt;
&lt;/span&gt;&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s report&lt;/span&gt;&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;The group has 116 members with 100 members registered on the vetsurgeon.org forum. &lt;/p&gt;
&lt;p&gt;There are 63 members attending this meeting.&lt;/p&gt;
&lt;p&gt;Please join the web forum&lt;/p&gt;
&lt;p&gt;Subs are due and should be paid at the time we are paying for the PreBSAVA satellite meeting.&lt;/p&gt;
&lt;p&gt;There was majority agreement that it should be paid for all in one sum. Although access to web forum will be restricted to subscribed members only.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Treasurers Report:- Summary&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;We would like to thank the Treasurer and Dr. Jason Woodward for compiling and auditing the accounts respectively.&lt;/p&gt;
&lt;p&gt;In 2009 the society made a profit but it was less than appearences would seem as we had to bank 2 years worth of Hill&lt;/p&gt;
&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s sponsorship (and they are thanked for that). Therefore the corrected profit for 2009 was somewhat less that the profit in 2008.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;The loss for the 2009 meeting was just over &amp;pound;1000 greater than in 2008 but if we take member subscriptions and sponsorship into account we do break even.&lt;/p&gt;
&lt;p&gt;The major cost to the society is catering and the cost of the meeting was an extra &amp;pound;800 this year.&lt;/p&gt;
&lt;p&gt;We will investigate the cost of a cold stand up buffet to see if catering costs can be reduced.&lt;/p&gt;
&lt;p&gt;Obviously bank interest is very low at present so not giving a significant income. &lt;/p&gt;
&lt;p&gt;We currently have 144 members and 100 members enrolled on vetsurgeon.org forum&lt;/p&gt;
&lt;p&gt;　&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Election of Committee members&lt;/p&gt;
&lt;/span&gt;&lt;b&gt;
&lt;p&gt;Vice Chair:- &lt;/p&gt;
&lt;/b&gt;
&lt;p&gt;IB is to deal with the forum &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;Programme committee:- &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;PR;- &lt;/p&gt;
&lt;b&gt;
&lt;p&gt;Re-election&lt;/p&gt;
&lt;/b&gt;
&lt;p&gt;The Post of Vice Chair was not refilled.&lt;/p&gt;
&lt;p&gt;Rebecca Littler (ICC liason) , Ian Battersby (to deal with the forum) and Allie Woodward (secretary) were reelected onto the committee.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;New Members of SAMSoc&lt;/p&gt;
&lt;p&gt;There was unanimous approval of a block vote of new members of the society.&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Programme committee report by Stijn Nielsson&lt;/p&gt;
&lt;/span&gt;&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Feedback from 2009 meeting&lt;/p&gt;
&lt;p&gt;Largely positive with a mix of comments on a mixture of topics. With trends. Generally the case reports were very positively received. Some people had the opinion that the case reports shortened the time available for the lectures, and whether members would like to increase the number of case reports.&lt;/p&gt;
&lt;p&gt;Some members prefer the day to focus on a single topic area others would prefer a mixture. Obviously this variation in opinion cannot be wholly fulfilled and this year we opted for a mixture of talks with a trend in the thromoboembolism theme. &lt;/p&gt;
&lt;p&gt;This year the room is hot, whereas last year it was cold!&lt;/p&gt;
&lt;p&gt;Human speakers appear to provide shorter summary lecture notes than their veterinary counterparts.&lt;/p&gt;
&lt;p&gt;Please would members give feedback on this years meeting .. It may be possible to put a poll on vetsurgeon.org. regarding the interactive case reports.&lt;/p&gt;
&lt;p&gt;Travel Scholarship - this should be attractive benefit for membership not advertised well. Another incentive to get on forum and the price of entering for the scholarship is to provide a written piece on the travel undertaken. This report could be published in the veterinary Times would give publicity for the society. It would be interesting to gain insights as to what the value of the travel scholarship should be.&lt;/p&gt;
&lt;p&gt;Kate Murphy is reconsidering the membership structure and looking at access to RCVS library - Mark Dunning pointed out that there had been a reduction in the number of journals offered in their archives.&lt;/p&gt;
&lt;p&gt;　&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;ANTIBIOTIC Working Group&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;　&lt;/p&gt;
&lt;p&gt;IB:- The Antibiotic Working group has been set up to try to come up with a poster of guidelines for the use of antibiotics in some clinical situations. Progress has been slow initially. It is a large project and we hope to back it up with information. The BSAVA Scientific committee is backing this project and possibly we will produce a back up document. Likely it will be a 2 year project and may not cover all situations. The hope is that general practitioners will use the guidelines and prevent the restrictions to antibiotic use that were described in Sue Dawson&lt;/p&gt;
&lt;span lang="EN-GB"&gt;&amp;rsquo;&lt;/span&gt;
&lt;p&gt;&lt;span lang="EN"&gt;s lecture.&lt;/span&gt;&lt;span style="font-size:x-small;"&gt;&lt;font size="2"&gt;&lt;span lang="EN-GB"&gt;
&lt;p&gt;The length of the lectures are to be changed to 45 minutes per lecture. 　&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Date of next meeting&lt;/p&gt;
&lt;/span&gt;
&lt;p&gt;Wednesday 30&lt;sup&gt;th&lt;/sup&gt; March, 2011&lt;/p&gt;
&lt;/b&gt;&lt;/span&gt;&lt;/font&gt;&lt;/span&gt;&lt;span lang="EN-GB"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;b&gt;&lt;span style="text-decoration:underline;"&gt;
&lt;p&gt;Any Other Business&lt;/p&gt;
&lt;/span&gt;&lt;/b&gt;&lt;/b&gt;&lt;/span&gt;:-&lt;/b&gt;&lt;/b&gt;&lt;/span&gt;.&lt;/b&gt;&lt;/b&gt;David Walker was unanimously voted into the PR role.&lt;/b&gt;Mark Dunning was unanimously voted as a member of programme committee.&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/b&gt;&lt;/p&gt;
&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Efficacy of masitinib in dogs with steroid-resistant inflammatory bowel disease</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/956/efficacy-of-masitinib-in-dogs-with-steroid-resistant-inflammatory-bowel-disease</link><pubDate>Wed, 08 Sep 2010 15:16:37 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:070d23c3-e5dc-4940-a81d-242ae4890741</guid><dc:creator>Fabio Procoli</dc:creator><description>Current Revision posted to Small Animal Medicine Society by Fabio Procoli on 9/8/2010 3:16:37 PM&lt;br /&gt;
&lt;p&gt;&lt;strong&gt;Fabio Procoli&lt;/strong&gt; DMV MRCVS, Senior Clinical Training Scholar in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Karin Allenspach&lt;/strong&gt; Dr.med.vet. PhD DECVIM-CA MRCVS, Senior Lecturer in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Idiopathic inflammatory bowel disease (IBD) is the most common cause of chronic intestinal disease in dogs. Current treatment protocols most often involve the use of immunosuppressive doses of corticosteroids to reduce intestinal mucosal inflammation and achive remission.&lt;/p&gt;
&lt;p&gt;However a number of dogs with IBD treated with corticosteroids have either no response at all to the drug or relapse after weeks to months of treatment. In addition, treatment with prednisolone often results in unacceptable side effects.&lt;/p&gt;
&lt;p&gt;Masitinib&amp;nbsp;is a&amp;nbsp;protein tyrosine kinase inhibitor licensed for the use in dogs with mast cell tumours, where it has proven efficacy. There also reports that this drug can decrease inflammation in people with several immune mediated disorders, including IBD.&lt;/p&gt;
&lt;p&gt;The Veterinary Clinical Sciences at the Royal Veterinary College is performing a clinical trial&amp;nbsp;to evaluate the clinical efficacy of masitinib as a sole treatment for canine IBD in steroid-refractory cases over a period of 8 weeks. &lt;/p&gt;
&lt;p&gt;Inclusion criteria:&lt;/p&gt;
&lt;p&gt;- Diagnosis of IBD after excluding other causes of chronic diarrhoea based on&amp;nbsp; routine diagnostic test:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;faecal parasitology&lt;/li&gt;
&lt;li&gt;faecal bacteriology&lt;/li&gt;
&lt;li&gt;CBC, serum biochemistry, urinalysis&lt;/li&gt;
&lt;li&gt;abdominal ultrasound &lt;/li&gt;
&lt;li&gt;serum TLI&lt;/li&gt;
&lt;li&gt;serum cobalamine and folate concentration&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;- the presence of inflammatory cell infiltrates in mucosal biopsies obtained by gastroduodenoscopy and/or colonoscopy.&lt;/p&gt;
&lt;p&gt;- Previous treatment with corticosteroids for at least 4 weeks with only minimal or no response&lt;/p&gt;
&lt;p&gt;Exclusion criteria:&lt;/p&gt;
&lt;p&gt;- Unwillingness of owner to participate&lt;/p&gt;
&lt;p&gt;-&amp;nbsp;Cases that don&amp;#39;t meet the inclusion criteria (incomplete diagnostic tests)&lt;/p&gt;
&lt;p&gt;Following inclusion in the study&amp;nbsp;all dogs will receive masitinib orally at 12.5mg/kg/day for 8 weeks. At the time of inclusion to the study all cases will be scored with a clinical activity index (CCECAI) and serum biochemistry (including albumin)&amp;nbsp;will be performed and every two weeks thereafter for the duration of the study. The latter test will serve to evaluate clinical efficacy, assess the progress of the disease&amp;nbsp;and also identify the presence of adverse effects of the drug. &lt;/p&gt;
&lt;p&gt;Consultation, physical examination, blood work and costs of the drug will be covered by the RVC. Please note that the drug will not be dispensed beyond the duration of the study (8 weeks).&lt;/p&gt;
&lt;p&gt;The study has been approved by the RVC Ethics Committee.&lt;/p&gt;
&lt;h4&gt;We welcome suitable cases therefore if you have a&amp;nbsp;dog diagnosed with IBD&amp;nbsp;that has not responded to conventional immunosuppressive therapy or if you have any queries or doubt about the suitability of&amp;nbsp;a case please contact us at the following email address:&lt;/h4&gt;
&lt;p&gt;&lt;span style="font-size:11pt;color:#1f497d;font-family:&amp;#39;Calibri&amp;#39;,&amp;#39;sans-serif&amp;#39;;mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-latin;mso-bidi-font-family:&amp;#39;Times New Roman&amp;#39;;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;"&gt;&lt;a  target='_blank'  href="mailto:cic@rvc.ac.uk"&gt;cic@rvc.ac.uk&lt;/a&gt;&lt;/span&gt;&lt;a href="mailto:ibd.masitinib@hotmail.co.uk"&gt;&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Thank you all&lt;/p&gt;
&lt;p&gt;Fabio Procoli&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Efficacy of masitinib in dogs with steroid-resistant inflammatory bowel disease</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/956/efficacy-of-masitinib-in-dogs-with-steroid-resistant-inflammatory-bowel-disease/revision/3</link><pubDate>Wed, 08 Sep 2010 14:05:28 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:070d23c3-e5dc-4940-a81d-242ae4890741</guid><dc:creator>Fabio Procoli</dc:creator><description>Revision 3 posted to Small Animal Medicine Society by Fabio Procoli on 9/8/2010 2:05:28 PM&lt;br /&gt;
&lt;p&gt;&lt;strong&gt;Fabio Procoli&lt;/strong&gt; DMV MRCVS, Senior Clinical Training Scholar in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Karin Allenspach&lt;/strong&gt; Dr.med.vet. PhD DECVIM-CA MRCVS, Senior Lecturer in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Idiopathic inflammatory bowel disease (IBD) is the most common cause of chronic intestinal disease in dogs. Current treatment protocols most often involve the use of immunosuppressive doses of corticosteroids to reduce intestinal mucosal inflammation and achive remission.&lt;/p&gt;
&lt;p&gt;However a number of dogs with IBD treated with corticosteroids have either no response at all to the drug or relapse after weeks to months of treatment. In addition, treatment with prednisolone often results in unacceptable side effects.&lt;/p&gt;
&lt;p&gt;Masitinib&amp;nbsp;is a&amp;nbsp;protein tyrosine kinase inhibitor licensed for the use in dogs with mast cell tumours, where it has proven efficacy. There also reports that this drug can decrease inflammation in people with several immune mediated disorders, including IBD.&lt;/p&gt;
&lt;p&gt;The Veterinary Clinical Sciences at the Royal Veterinary College is performing a clinical trial&amp;nbsp;to evaluate the clinical efficacy of masitinib as a sole treatment for canine IBD in steroid-refractory cases over a period of 8 weeks. &lt;/p&gt;
&lt;p&gt;Inclusion criteria:&lt;/p&gt;
&lt;p&gt;- Diagnosis of IBD after excluding other causes of chronic diarrhoea based on&amp;nbsp; routine diagnostic test:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;faecal parasitology&lt;/li&gt;
&lt;li&gt;faecal bacteriology&lt;/li&gt;
&lt;li&gt;CBC, serum biochemistry, urinalysis&lt;/li&gt;
&lt;li&gt;abdominal ultrasound &lt;/li&gt;
&lt;li&gt;serum TLI&lt;/li&gt;
&lt;li&gt;serum cobalamine and folate concentration&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;- the presence of inflammatory cell infiltrates in mucosal biopsies obtained by gastroduodenoscopy and/or colonoscopy.&lt;/p&gt;
&lt;p&gt;- Previous treatment with corticosteroids for at least 4 weeks with only minimal or no response&lt;/p&gt;
&lt;p&gt;Exclusion criteria:&lt;/p&gt;
&lt;p&gt;- Unwillingness of owner to participate&lt;/p&gt;
&lt;p&gt;-&amp;nbsp;Cases that don&amp;#39;t meet the inclusion criteria (incomplete diagnostic tests)&lt;/p&gt;
&lt;p&gt;Following inclusion in the study&amp;nbsp;all dogs will receive masitinib orally at 12.5mg/kg/day for 8 weeks. At the time of inclusion to the study all cases will be scored with a clinical activity index (CCECAI) and serum biochemistry (including albumin)&amp;nbsp;will be performed and every two weeks thereafter for the duration of the study. The latter test will serve to evaluate clinical efficacy, assess the progress of the disease&amp;nbsp;and also identify the presence of adverse effects of the drug. &lt;/p&gt;
&lt;p&gt;Consultation, physical examination, blood work and costs of the drug will be covered by the RVC. Please note that the drug will not be dispensed beyond the duration of the study (8 weeks).&lt;/p&gt;
&lt;p&gt;The study has been approved by the RVC Ethics Committee.&lt;/p&gt;
&lt;h4&gt;We welcome suitable cases therefore if you have a&amp;nbsp;dog diagnosed with IBD&amp;nbsp;that has not responded to conventional immunosuppressive therapy or if you have any queries or doubt about the suitability of&amp;nbsp;a case please contact us at the following email address:&lt;/h4&gt;
&lt;p&gt;&lt;a  target='_blank'  href="mailto:ibd.masitinib@hotmail.co.uk"&gt;ibd.masitinib@hotmail.co.uk&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Thank you all&lt;/p&gt;
&lt;p&gt;Fabio Procoli&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Efficacy of masitinib in dogs with steroid-resistant inflammatory bowel disease</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/956/efficacy-of-masitinib-in-dogs-with-steroid-resistant-inflammatory-bowel-disease/revision/2</link><pubDate>Wed, 08 Sep 2010 10:46:26 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:070d23c3-e5dc-4940-a81d-242ae4890741</guid><dc:creator>Fabio Procoli</dc:creator><description>Revision 2 posted to Small Animal Medicine Society by Fabio Procoli on 9/8/2010 10:46:26 AM&lt;br /&gt;
&lt;p&gt;&lt;strong&gt;Fabio Procoli&lt;/strong&gt; DMV MRCVS, Senior Clinical Training Scholar in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Karin Allenspach&lt;/strong&gt; Dr.med.vet. PhD DECVIM-CA MRCVS, Senior Lecturer in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Idiopathic inflammatory bowel disease (IBD) is the most common cause of chronic intestinal disease in dogs. Current treatment protocols most often involve the use of immunosuppressive doses of corticosteroids to reduce intestinal mucosal inflammation and achive remission.&lt;/p&gt;
&lt;p&gt;However a number of dogs with IBD treated with corticosteroids have either no response at all to the drug or relapse after weeks to months of treatment. In addition, treatment with prednisolone often results in unacceptable side effects.&lt;/p&gt;
&lt;p&gt;Masitinib&amp;nbsp;is a&amp;nbsp;protein tyrosine kinase inhibitor licensed for the use in dogs with mast cell tumours, where it has proven efficacy. There also reports that this drug can decrease inflammation in people with several immune mediated disorders, including IBD.&lt;/p&gt;
&lt;p&gt;The Veterinary Clinical Sciences at the Royal Veterinary College is performing a clinical trial&amp;nbsp;aiming to evaluate the clinical efficacy of masitinib as a sole agent treatment for canine IBD in steroid-refractory cases over a period of 8 weeks. &lt;/p&gt;
&lt;p&gt;Inclusion criteria:&lt;/p&gt;
&lt;p&gt;- Diagnosis of IBD after excluding other causes of chronic diarrhoea based on&amp;nbsp; routine diagnostic test:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;faecal parasitology&lt;/li&gt;
&lt;li&gt;faecal bacteriology&lt;/li&gt;
&lt;li&gt;CBC, serum biochemistry, urinalysis&lt;/li&gt;
&lt;li&gt;abdominal ultrasound &lt;/li&gt;
&lt;li&gt;serum TLI&lt;/li&gt;
&lt;li&gt;serum cobalamine and folate concentration&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;- the presence of inflammatory cell infiltrates in mucosal biopsies obtained by gastroduodenoscopy and/or colonoscopy.&lt;/p&gt;
&lt;p&gt;- Previous treatment with corticosteroids for at least 4 weeks with only minimal or no response&lt;/p&gt;
&lt;p&gt;Exclusion criteria:&lt;/p&gt;
&lt;p&gt;- Unwillingness of owner to participate&lt;/p&gt;
&lt;p&gt;-&amp;nbsp;Cases that don&amp;#39;t meet the inclusion criteria (incomplete diagnostic tests)&lt;/p&gt;
&lt;p&gt;Following inclusion in the study&amp;nbsp;all dogs will receive masitinib orally at 12.5mg/kg/day for 8 weeks. At the time of inclusion to the study all cases will be scored with a clinical activity index (CCECAI) and serum biochemistry (including albumin)&amp;nbsp;will be performed and every two weeks thereafter for the duration of the study. The latter test will serve to evaluate clinical efficacy and also identify the presence of adverse effects of the drug. &lt;/p&gt;
&lt;p&gt;Consultation, physical examination, blood work and costs of the drug will be covered by the RVC. Please note that the drug will not be dispensed behond the duration of the study (8 weeks).&lt;/p&gt;
&lt;p&gt;The study has been approved by the RVC Ethics Committee.&lt;/p&gt;
&lt;h4&gt;We welcome suitable cases therefore if you have a&amp;nbsp;dog diagnosed with IBD&amp;nbsp;that has not responded to conventional immunosuppressive therapy or if you have any queries or doubt about the suitability of&amp;nbsp;a case please contact us at the following email address:&lt;/h4&gt;
&lt;p&gt;&lt;a  target='_blank'  href="mailto:ibd.masitinib@hotmail.co.uk"&gt;ibd.masitinib@hotmail.co.uk&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Thank you all&lt;/p&gt;
&lt;p&gt;Fabio Procoli&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item><item><title>Efficacy of masitinib in dogs with steroid-resistant inflammatory bowel disease</title><link>https://www.vetsurgeon.org/associations/samsoc/w/samsoc-wiki/956/efficacy-of-masitinib-in-dogs-with-steroid-resistant-inflammatory-bowel-disease/revision/1</link><pubDate>Wed, 08 Sep 2010 10:44:49 GMT</pubDate><guid isPermaLink="false">146601cc-3922-4be7-9974-7e1d4e45a66b:070d23c3-e5dc-4940-a81d-242ae4890741</guid><dc:creator>Fabio Procoli</dc:creator><description>Revision 1 posted to Small Animal Medicine Society by Fabio Procoli on 9/8/2010 10:44:49 AM&lt;br /&gt;
&lt;p&gt;&lt;strong&gt;Fabio Procoli&lt;/strong&gt; DMV MRCVS, Senior Clinical Training Scholar in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Karin Allenspach&lt;/strong&gt; Dr.med.vet. PhD DECVIM-CA MRCVS, Senior Lecturer in Small Animal Internal Medicine&lt;/p&gt;
&lt;p&gt;&amp;nbsp;&lt;/p&gt;
&lt;p&gt;Idiopathic inflammatory bowel disease (IBD) is the most common cause of chronic intestinal disease in dogs. Current treatment protocols most often involve the use of immunosuppressive doses of corticosteroids to reduce intestinal mucosal inflammation and achive remission.&lt;/p&gt;
&lt;p&gt;However a number dogs with IBD treated with corticosteroids have either no response at all to the drug or relapse after weeks to months of treatment. In addition, treatment with prednisolone often results in unacceptable side effects.&lt;/p&gt;
&lt;p&gt;Masitinib&amp;nbsp;is a&amp;nbsp;protein tyrosine kinase inhibitor licensed for the use in dogs with mast cell tumours, where it has proven efficacy. There also reports that this drug can decrease inflammation in people with immune mediated disorders, including IBD.&lt;/p&gt;
&lt;p&gt;The Veterinary Clinical Sciences at the Royal Veterinary College is performing a clinical trial looking to evaluate the clinical efficacy of masitinib as a sole agent treatment for canine IBD in steroid-refractory cases over a period of 8 weeks. We are looking to recruit cases&amp;nbsp;to enrol in the study. &lt;/p&gt;
&lt;p&gt;Inclusion criteria:&lt;/p&gt;
&lt;p&gt;- Diagnosis of IBD after excluding other causes of chronic diarrhoea based on&amp;nbsp; routine diagnostic test:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;faecal parasitology&lt;/li&gt;
&lt;li&gt;faecal bacteriology&lt;/li&gt;
&lt;li&gt;CBC, serum biochemistry, urinalysis&lt;/li&gt;
&lt;li&gt;abdominal ultrasound &lt;/li&gt;
&lt;li&gt;serum TLI&lt;/li&gt;
&lt;li&gt;serum cobalamine and folate concentration&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;- the presence of inflammatory cell infiltrates in mucosal biopsies obtained by gastroduodenoscopy and/or colonoscopy.&lt;/p&gt;
&lt;p&gt;- Previous treatment with corticosteroids for at least 4 weeks with only minimal or no response&lt;/p&gt;
&lt;p&gt;Exclusion criteria:&lt;/p&gt;
&lt;p&gt;- Unwillingness of owner to participate&lt;/p&gt;
&lt;p&gt;-&amp;nbsp;Cases that don&amp;#39;t meet the inclusion criteria (incomplete diagnostic tests)&lt;/p&gt;
&lt;p&gt;Following inclusion in the study&amp;nbsp;all dogs will receive masitinib orally at 12.5mg/kg/day for 8 weeks. At the time of inclusion to the study all cases will be scored with a clinical activity index (CCECAI) and serum biochemistry (including albumin)&amp;nbsp;will be performed and every two weeks thereafter for the duration of the study. The latter test will serve to evaluate clinical efficacy and also identify the presence of adverse effects of the drug. &lt;/p&gt;
&lt;p&gt;Consultation, physical examination, blood work and costs of the drug will be covered by the RVC. Please note that the drug will not be dispensed behond the duration of the study (8 weeks).&lt;/p&gt;
&lt;p&gt;The study has been approved by the RVC Ethics Committee.&lt;/p&gt;
&lt;h4&gt;We welcome suitable cases therefore if you have a&amp;nbsp;dog diagnosed with IBD&amp;nbsp;that has not responded to conventional immunosuppressive therapy or if you have any queries or doubt about the suitability of&amp;nbsp;a case please contact us at the following email address:&lt;/h4&gt;
&lt;p&gt;&lt;a  target='_blank'  href="mailto:ibd.masitinib@hotmail.co.uk"&gt;ibd.masitinib@hotmail.co.uk&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;Thank you all&lt;/p&gt;
&lt;p&gt;Fabio Procoli&lt;/p&gt;&lt;div style="clear:both;"&gt;&lt;/div&gt;
</description></item></channel></rss>